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ABSTRACT
ROLE OF NON-MUSCLE MYOSIN II AND CALCIUM IN
ZEBRAFISH MIDBRAIN-HINDBRAIN BOUNDARY
MORPHOGENESIS
by

Srishti Upasana Sahu
The University of Wisconsin-Milwaukee, 2015
Under the Supervision of Dr. Jennifer H. Gutzman, Ph.D.
Elucidating the molecular mechanisms that play a role in cellular morphogenesis
is critical to our understanding of brain development and function. The midbrainhindbrain boundary (MHB) is one of the first folds in the vertebrate embryonic brain
and is highly conserved across species. We used the zebrafish MHB as a model
for determining the molecular mechanisms that regulate these cell shape changes.
Cellular morphogenesis is tightly regulated by signaling pathways that rearrange
the cytoskeleton and produce mechanical forces that enable changes in cell and
tissue morphology. The generation of force within a cell often depends on motor
proteins, particularly non-muscle myosins (NMII). We found that non-muscle
myosin IIA (NMIIA) regulates cell length at the MHBC, while NMIIB regulates cell
width throughout the MHB region. The novel discovery of distinct roles for the NMII
proteins leads to the question of what directs them to function differentially. We
hypothesize that the two proteins are activated by differential upstream signaling
pathways. We investigated the role of calcium signaling in zebrafish MHB
morphogenesis. Inhibition of cytosolic calcium by the pharmacological drug, 2-APB
showed that calcium regulates MHBC cell length, a phenotype similar to NMIIA
ii

knockdown. We further show that the shorter MHBC cell length phenotype seen
by overactivation of NMII is rescued by inhibition of cytosolic calcium. Thus, we
hypothesize that calcium signals differentially to NMIIA, and not NMIIB. Further
investigation of these pathways will help answer the question of how NMII proteins
are regulated to carry out distinct functions. Identifying these mechanisms will
advance the understanding of the molecular basis for morphogenetic processes
during brain formation and are likely to be applicable to developmental events
throughout the embryo.
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CHAPTER 1
INTRODUCTION

A. BRAIN MORPHOGENESIS
Morphogenesis is a developmental process that gives shape to an organism and
may occur at the level of a cell or tissue. Proper shape elicits proper function and
this demonstrates the importance of morphogenesis in the context of structurefunction abnormalities. Developmental disorders such as neural tube defects result
from defects in morphogenesis and while birth defects are as frequent as one in
every thirty three babies, 70 percent of birth defect causes are still unknown
indicating the importance of determining the molecular mechanisms leading to
these developmental disorders (Rynn, 2009).
During development, tissue morphogenesis plays an important role in giving rise
to vital organs such as the brain, a highly complex and dynamic organ that controls
the entire body. Brain morphogenesis begins early in development and involves
the rearrangement of cells and folding of tissue sheets to give it a characteristic
shape. Any structural abnormality in the formation of the brain, as seen in neural
tube defects such as anencephaly and hydrocephaly can have adverse effects
often resulting in fatal disruption of regular brain function. Brain morphogenesis
begins with neurulation- the process of neural tube formation from the ectoderm
(Colas and Schoenwolf, 2001) (Fig. 1A). Post neurulation, the neural tube, formed
from a single layer of pseudo-stratified columnar epithelial cells, undergoes a
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series of morphogenetic changes leading to tissue folding that divides the tube into
the forebrain, midbrain and hindbrain (Lowery and Sive, 2009) (Fig. 1B). This
process of fold formation occurs alongside the formation of the brain ventricular
system within the neural tube. The ventricles of the brain constitute an
interconnected system of cavities where cerebrospinal fluid is produced and
circulated. The deepest point of constriction between the midbrain and hindbrain,
the midbrain-hindbrain boundary constriction (MHBC), is one of the first folds
formed during vertebrate brain morphogenesis (Gutzman et al., 2008). The
midbrain eventually forms part of the tectum, responsible for auditory and visual
reflexes in the adult brain; while the hindbrain forms the cerebellum, pons and
medulla, parts of the adult brain with vital functions in motor control, cognitive
functions, hearing and equilibrium (Louvi et al., 2003). Being a distinct and
important first fold in the developing vertebrate brain, the midbrain-hindbrain
boundary serves as a useful model to study brain formation and has allowed us to
uncover novel mechanisms of tissue morphogenesis (Gutzman et al., 2015) .

B. ZEBRAFISH MHB DEVELOPMENT AND MORPHOGENESIS
MODEL
The midbrain-hindbrain boundary (MHB) is one of the earliest folds visible in the
embryonic brain and is highly conserved across vertebrate species including
human, mouse, chick and zebrafish (Lowery and Sive, 2009). The MHB tissue is
the isthmic organizer, a neural signaling center that expresses transcription factors
and signaling molecules that pattern the tissue to give it a mesencephalic

3

(midbrain) or metencephalic (hindbrain) fate (Louvi et al., 2003). Before
morphogenesis, the neural tissue is patterned by the Fgf and Wnt genes to
establish cell fates. Fgf8b activates the Ras-ERK pathway and induces cerebellar
development (Sato et al., 2004). Wnt8 is involved in posteriorisation of the neural
tube and is important for the onset of otx2 and gbx1 expression (Rhinn et al., 2005).
Otx2 expression establishes a midbrain fate while gbx2 determines a hindbrain
fate (Barkovich et al., 2009; Dworkin and Jane, 2013). The different stages of MHB
tissue establishment are positioning, induction, and maintenance. The expression
of patterning genes involved during each these steps have been relatively well
studied (Martinez, 2001). Morphogenesis is now considered a fourth, distinct stage
in MHB development and the molecular mechanisms that regulate MHB
morphogenesis are the focus of more recent studies (Giraldez et al., 2005;
Gutzman et al., 2008).
We use zebrafish as a model system to study the mechanisms involved in the
formation of the midbrain-hindbrain boundary. Zebrafish is favorable due to various
advantages. Zebrafish are easy to handle, breed, and have a faster embryonic
developmental timeline when compared to other models (Kimmel et al., 1995).
They produce large clutches of embryos which undergo synchronous
development, allowing for a large sample size in experiments. Ex-utero
development and transparency of embryos make it an excellent vertebrate model
for early developmental studies because it allows for micromanipulation and highresolution imaging to visualize cell shapes. Importantly, 70 percent of protein-
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coding human genes have at least one ortholog in the zebrafish, which helps to
correlate findings between the two organisms (Howe et al., 2013).
Zebrafish midbrain-hindbrain boundary morphogenesis occurs between 18 and 24
hours post fertilization (hpf) (Fig. 2). At 18 hpf, or 18 somite stage (ss), the
hindbrain ventricle first starts opening, followed by the midbrain ventricle at around
20 hpf, or 22 ss. As these ventricles inflate due to secretion of embryonic
cerebrospinal fluid, the neural tube gets segregated into three regions- the
forebrain, midbrain and hindbrain. Boundaries between each of these regions
begin appearing as a result of folding of the neuroepithelium. The junction between
the midbrain and the hindbrain, the midbrain-hindbrain boundary is seen as a
distinct fold in the tissue starting at 20 hpf (Gutzman et al., 2008). This progressive
formation of the MHB to a distinct fold in the early neural tube structure can be
observed through further time points from 22 hpf (24 ss) to 24 hpf (prim-6) (Fig.
2A-D). The cell shape changes occurring during this time have been previously
characterized (Gutzman et al., 2008). At 17 hpf, the neuroepithelial cells of the
MHB are of similar length. By 21-22 hpf, cells at the MHB shorten by about 25% in
comparison to cells on the hindbrain side of the MHB and they further undergo
apical expansion and basal constriction such that by 24 hpf, the midbrain-hindbrain
boundary constriction (MHBC) is completely formed and the ventricles are open
(Gutzman et al., 2008). We were interested in the early time point of 22 hpf or 24
ss, because this is when the tissue first folds between the midbrain and the
hindbrain,

forming

the

midbrain-hindbrain

boundary.

Understanding

the
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mechanisms that drive the formation of this initial fold will enable us to understand
more complex morphogenetic processes that occur during development.

C. CELL SHAPE CHANGES LEAD TO TISSUE
MORPHOGENESIS
During epithelial tissue morphogenesis, cells undergo changes in shape to enable
the tissue to fold. Cellular morphogenesis can occur in various ways depending on
the morphogenetic event required during that particular time of development.
Some cell shape change mechanisms have been extensively studied in various
models and will be the focus of this section.
An epithelial tissue has a distinct apical-basal polarity and cells of that tissue can
change shape in multiple ways (Fig. 3). Cells can elongate to become columnar
which happens when neural plate is formed, as the first step of neurulation
(Schoenwolf and Franks, 1984) (Fig. 3A). Epithelial cells also undergo shortening
along the apicobasal axis as seen in initial midbrain-hindbrain boundary formation,
leading to tissue folding (Fig. 3B) (Gutzman et al., 2008). Additionally, shortening
may occur along the lateral sides to cause flattening of tissue as seen during
epiboly in zebrafish and frog embryos, and in drosophila wing imaginal disc
formation (Fig. 3C) (Barkovich et al., 2009; Fristrom, 1988; Keller, 1980). In the
zebrafish Kupffer’s vesicle, a combination of regionalized cell shape changes
occur where anterior cells elongate and posterior cells shorten, displaying apical
expansion (Wang et al., 2012). Additionally, cells can undergo changes on either
the apical side or the basal side. Apical constriction is a common cell shape change
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that occurs during many developmental processes (Fig. 3D) (Sawyer et al., 2010).
It occurs during ventral furrow formation in Drosophila (Kam et al., 1991; Leptin,
1999), gastrulation in C.elegans (Lee and Goldstein, 2003) and in vertebrates,
involving bottle cells of the Xenopus dorsal marginal zone (Lee and Harland, 2007)
and cells in the mouse embryo during neural tube closure (Bush et al., 1990).
Although apical constriction has been well studied, examples of basal constriction
in development are few (Fig. 3E). During brain morphogenesis, cells at the
midbrain-hindbrain boundary undergo basal constriction to form the distinct
constriction between the midbrain and hindbrain (Gutzman et al., 2008). Basal
constriction has also been described in zebrafish during optic cup morphogenesis
(Martinez-Morales et al., 2009).
Individual cell shape changes lead to tissue morphogenesis and the basic cell
shape changes discussed above are usually a precursor step to more complicated
tissue shape changes like folding, invagination and evagination. Invagination
occurs when the epithelial tissue folds, often as a consequence of apical
constriction (Llimargas and Casanova, 2010), while evagination leads to
outpocketing of cells (Schock and Perrimon, 2002).
Cell shape changes are vital to morphogenesis and although there have been
studies in various organisms during different stages of development, extensive
studies of cellular morphogenesis in vertebrate systems is lacking. Here, we have
studied the cell shape changes, and the molecular mechanisms by which those
changes are regulated during midbrain-hindbrain boundary morphogenesis in a
vertebrate model, the zebrafish.
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D. FACTORS INFLUENCING CELL AND TISSUE
MORPHOGENESIS
Morphogenetic processes are regulated by multiple factors involving tissue
specific gene expression and protein regulation. Genes are transcribed and mRNA
is translated to produce functional proteins. These proteins signal downstream to
direct mechanical changes that ultimately cause cell and tissue morphogenesis
(Fig. 4). Mechanical forces are ones that govern the architecture of the cell and
establish the stability of the tissue. This stability of epithelia is dependent on two
factors- the cytoskeleton and the extracellular matrix, which determines the
strength and structure of the cell inside and outside (Fletcher and Mullins, 2010).
Some of these factors that are critically important for morphogenesis will be
discussed next.
Cytoskeleton
The cytoskeleton is a network of intracellular proteins that comprise of
microfilaments, microtubules and intermediate filaments. Within the cell, the
cytoskeleton gives it a backbone of support. Most cell shape changes discussed
in the previous section require microfilaments or microtubules to carry out shape
changes, and these will be discussed next (Mammoto and Ingber, 2010).
Actomyosins
Actin filaments are helical polymers of the protein, actin. This cytoskeletal
component is highly enriched at the cell periphery, forming the cell cortex. Myosins
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are specialized motor proteins that associate with actin and move along actin
filaments to carry out force transduction (Fletcher and Mullins, 2010). They are a
huge family of proteins, and non-muscle myosins II are a class of proteins found
in all cells that are actively involved in cellular morphogenesis. Actomyosin
complexes are known to play an important part in a variety of cellular functions
involving cell motility, cell division, maintenance of tissue integrity, morphogenesis,
and cell shape (Vicente-Manzanares et al., 2009). Apical constriction, one of the
well-studied cell shape changes discussed above, is attributed to actomyosin
activity. It is responsible for pulsed contractions that drive morphogenetic
processes during gastrulation in C. elegans, Drosophila and Xenopus (Lee and
Goldstein, 2003; Lee and Harland, 2007; Martin et al., 2009). Apical constriction is
just one example depicting the role of actomyosins, as they play a role in almost
all other cell shape changes (Fristrom, 1988; Schock and Perrimon, 2002).
Microtubules
The cytoskeleton is also comprised of microtubules, which are polymers of the
protein tubulin and they arise from the centrosome. Microtubules are associated
with the motor proteins, kinesin, that move away from the centrosome and dynein,
that move towards the centrosome (Fletcher and Mullins, 2010). Microtubules are
primarily responsible for cell division and cargo movement across the cell but they
are also required for cell shape maintenance in events such as gastrulation in
Xenopus and zebrafish (Lee and Harland, 2007; Sepich et al., 2011). Disruption of
microtubule networks leads to increase in actin networks and adhesion dependent
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signaling which hints toward microtubule involvement in regulation of cell shape
(Elbaum et al., 1999; Rodionov et al., 1993).
Extracellular matrix
The physical properties of tissues are also determined by the extracellular matrix
(ECM), which is composed of a variety of polysaccharides and proteins that form
a meshwork outside the cell. The proteins produced here can be fibrous such as
collagen and elastin, or adhesive, such as fibronectin and laminin. In epithelial
cells, the boundary between the epithelium and the underlying connective tissue
is called the basal lamina and laminin allows attachment of the tissue to the basal
lamina (Parsons et al., 2010). Epithelial tissues have an apical-basal polarity with
the lamina being on the basal side. During neural tube morphogenesis, constriction
along the basal side allows formation of the zebrafish midbrain-hindbrain
boundary, and this process has been shown to be laminin dependent (Gutzman et
al., 2008).
Cell adhesion
Cell adhesion is the binding of cells within a tissue, to each other or to the
extracellular matrix and is an important factor in morphogenesis, especially when
cell movement is involved. The basal lamina is connected to the cell through cellmatrix adhesion molecules, integrins. Integrins are transmembrane receptors that
are connected to the ECM through laminin and internally, to cytoskeletal actin
stress filaments which allow the transmission of physical forces through the tissue,
enabling morphogenesis (Barone and Heisenberg, 2012). Focal adhesion
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molecules serve as a mechanical link to transduce force between the cell and the
matrix. Integrin mediated focal adhesion kinase (FAK) signaling connects the basal
lamina to intracellular actomyosins (Westhoff et al., 2004). FAK is localized at focal
adhesions, interacts with paxillin, and is required for microtubule and spindle
reorientation, making it essential for epithelial morphogenesis, determined by
studies in Xenopus embryos and human cell lines. (Petridou and Skourides, 2014).
Adherens junctions anchor the cytoskeleton, specifically actin filaments of a cell to
that of another cell or the ECM. Neighboring cells within the epithelial tissue are
connected through cell-cell adhesion molecules, cadherins. Cadherins are calcium
dependent cell adhesion molecules and they play an important role in brain and
nervous system development (Redies and Takeichi, 1996). Various cadherin
isoforms are required during different stages of nervous system development such
as neural tube and neuroepithelial layer formation, boundary formation and in the
formation of brain nuclei and ganglia (Hirano and Takeichi, 2012).
Cell migration
Cell migration, or movement of cells, is critical to development as it allows cells to
reach their destined location where they can differentiate and lead to development
of organs (Aman and Piotrowski, 2010). Some of the most widely studied migratory
events are gastrulation and neural crest cell migration. Cell migration in individual
cells occurs through extension of actin filled lamellipodia, indicating the importance
of the cytoskeleton in cellular morphogenesis (Giannone et al., 2007; Ponti et al.,
2004). A decrease in cell adhesion causes an increase in cell motility, showing the
interdependence of some of the factors discussed (Du et al., 2012).
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Cell intercalation
Cell intercalation is the interspersing of individual cells between other cells and is
also an important factor in some cellular morphogenetic events. The classic
example of cell intercalation occurs during the process of convergence and
extension. During this process mediolateral cells intercalate between cells along
the anteroposterior axis of the embryo resulting in its narrowing and elongation
along the anteroposterior body axis (Sepich et al., 2005). Cells also undergo
rearrangement in the form of radial intercalation as seen during epiboly in Xenopus
embryos where the inner layer of cells move out to the superficial layer and
undergo convergence and extension. This process is also critically dependent
upon cell-cell adhesion, again showing interconnection between factors (Marsden
and DeSimone, 2001).
Cell division
Morphogenetic changes can occur due to the active growth of tissue which is
regulated by region specific increases in cell proliferation, making cell proliferation
another essential regulator of morphogenesis. In kidney development, the
elongation of renal tubes requires extensive cell division (Jung et al., 2005). Wound
healing is another example where cell division is required for replacement of lost
or damaged tissue. In the drosophila wing imaginal disc, cells respond to tissue
damage by changing their cell division orientation (Ruiz and Serras, 2014). In
contrast to increased cell division, at times, cell division is stalled for the
morphogenetic event to proceed, as seen in drosophila gastrulation to enable cell
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shape changes (Seher and Leptin, 2000). In the zebrafish brain, greater cell
proliferation is observed in the midbrain and hindbrain ventricle regions of the
neural tube, indicating the role of cell proliferation in ventricle inflation (Lowery and
Sive, 2005).
Cell death
Cell death is an integral process in development and has been described
classically in C. elegans to occur by a tightly controlled genetic pathway involving
genes ced-3, ced-4 and ced-9 that induce programmed cell death, apoptosis (Ellis
et al., 1991). Cells in the interdigital spaces during animal limb formation undergo
extensive apoptosis (Merino et al., 1999) and significant amounts of cell death
occurs during Drosophila head involution and moth metamorphosis (Ellis et al.,
1991; Grether et al., 1995).
Thus, morphogenesis can be controlled through a variety of complex processes.
Elucidating the molecular mechanisms that regulate cell shape changes during
brain morphogenesis has been challenging due to the complexities of the
vertebrate system, the number of potential signaling pathways, and the likely
interactions between factors and pathways. We are using the developing zebrafish
midbrain-hindbrain boundary to understand the factors that regulate cell shape
changes during morphogenesis.

E. NON-MUSCLE MYOSIN II
Non-muscle myosin II proteins are cytoskeletal molecular motors present in all
cell types and, in association with actin filaments, carry out vital functions of cell
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division, cell migration and cell shape maintenance (Sellers, 2000). Using the
zebrafish midbrain-hindbrain boundary as a model, we studied the role of nonmuscle myosin II (NMII) in regulating cell shape changes occurring during this
process.
Classification and structure
The myosins are a superfamily of 35 classes of ATP-driven motor proteins that
work in coordination with actin filaments (Odronitz and Kollmar, 2007). The class
II myosin family includes NMII proteins which are present in all eukaryotic cells and
are known to be involved in cell migration, cell adhesion, cytokinesis and cell shape
(Sellers, 2000). Structurally, all class II myosins have a pair of heavy chains and
two pairs of light chains- essential and regulatory light chains (Golomb et al., 2004)
(Fig. 5). The heavy chains have a globular head domain and a long tail domain
that forms a coiled rod-like helical tail and a terminal non-helical end. The two pairs
of light chains are attached non-covalently to the heavy chain at the neck domain
(Fig. 5). The head domain contains the ATP and actin binding units which allow for
a change in conformation of the head domain enabling the molecule to convert
ATP energy to mechanical energy and move along actin filaments (Pollard and
Korn, 1973). The essential light chain is required for filament assembly and
stability, while the regulatory light chain, apart from filament stability, plays a critical
role in regulation of the active state of the molecule (Vicente-Manzanares et al.,
2009). Overall, myosin II can exist in a compact folded conformation due to its Cterminal tail domain being linked to the neck region by a ‘proline-kink’ or in an
elongated, filamentous form, where multiple myosin II molecules assemble in a

14

parallel or anti-parallel fashion to form thick filaments (Onishi and Wakabayashi,
1982; Trybus et al., 1982). In the filament form, actomyosin complexes can
transduce force within the cell and between cells in a tissue (Onishi and
Wakabayashi, 1982; Trybus et al., 1982).
Isoforms and functional differences
In mammals, there are three NMII isoforms, NMIIA, NMIIB and NMIIC, which differ
from each other by the structure of their heavy chains. These are encoded by the
genes myh9, myh10 and myh14, respectively (Fig. 6) (Golomb et al., 2004).
Zebrafish also have three isoforms with the exception that there are two ohnologs
for the human MYH9 gene- myh9 and myh9a (Flicek et al., 2014). Although the
three isoforms have a high degree of heavy chain sequence similarity with
differences mainly in the terminal tail portion, they have different binding affinities
to actin, which results in a difference in their kinetic properties (Heissler and
Manstein, 2011; Kovacs et al., 2003; Wang et al., 2011).
All three gene isoforms have a vast, yet distinct tissue expression. This suggests
that in spite of the high degree of sequence similarities between them, their
activation state and kinetic properties enable them to have potentially distinct
functions. NMIIA is predominantly expressed in platelets and spleen, NMIIB is
expressed largely in neuronal tissues (Calaminus et al., 2007). Most human fetal
tissues express significantly less amounts of NMIIC, in comparison to NMIIA and
NMIIB (Golomb et al., 2004). NMIIC also has low expression in adult mouse
tissues, with significant amounts detected only in lung tissue and in cell cultures
(Ma et al., 2010).
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Distinct functions for each of the isoforms have been identified which suggests that
each may be differentially regulated. NMIIA is important for cell migration and
knockout mice fail to develop a visceral endoderm layer (Sandquist et al., 2006).
NMIIB functions in cell motility and tissue organization and these knockout mice
display severe cardiovascular and brain defects including hydrocephaly (Getty et
al., 2011; Tullio et al., 1997; Tullio et al., 2001). Being a recently identified homolog,
compared to NMIIA and NMIIB, not much is known about the functional role and
kinetics of NMIIC (Golomb et al., 2004; Heissler and Manstein, 2013). It has a
lower homology of 62% between human and fish, compared to around 75% for
NMIIA and 90% for NMIIB, and is more closely related to muscle myosin than to
other NMII proteins (Flicek et al., 2014). Further, the NMIIC knockout mice survive
to adulthood with no obvious phenotypes, while their IIA and IIB counterparts do
not (Ma et al., 2010). As also mentioned earlier, NMIIC has low expression in fetal
tissues (Golomb et al., 2004). Due to these reasons, we have focused our current
study on the role of NMIIA and NMIIB in regulating brain morphogenesis.
Regulation of non-muscle myosin II activity
Activation by light chain phosphorylation
In the zebrafish, there are multiple isoforms of the myosin regulatory light chain;
however, only one isoform has been identified to be specific for non-muscle myosin
II (myl12.1) (Flicek et al., 2014). Activation of NMII molecules is primarily carried
out by the phosphorylation of the regulatory light chain at two sites- serine-19 and
threonine-18 (Somlyo and Somlyo, 2003). Phosphorylation at either ser-19 alone,
or both ser-19 and thr-18 increases the Mg2+-ATPase activity of myosin and its
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association with actin, causing activation of the entire molecule (Somlyo and
Somlyo, 2003; Vicente-Manzanares et al., 2009). The myosin specific enzyme,
myosin light chain kinase (MLCK), phosphorylates and activates the regulatory
myosin light chain (MLC) (Nishikawa et al., 1984). There are three MLCK isoformsa long non-muscle isoform, a short smooth muscle isoform, and a telokin with no
enzymatic activity (Guo et al., 2013). The non-muscle MLCK has been shown to
be involved in cell migration (Reynoso et al., 2007) and cell adhesion (Xu et al.,
2008). It is also known to be regulated in a calcium-calmodulin dependent manner
in smooth muscle (Martinsen et al., 2013; Mizuno et al., 2008). A variety of other
enzymes also phosphorylate the MLC and they include Rho, Rho associated
coiled-coil kinase (ROCK), myotonic dystrophy kinase-related cdc42-binding
kinase (MRCK), protein kinase A (PKA) and mitogen activated protein kinase
(MAPK), among others (Fig. 7) (Betapudi, 2014; Matsumura, 2005; VicenteManzanares et al., 2009). Myosin phosphatase dephosphorylates the MLC,
inactivating NMII. Rho also inhibits mypt1, a subunit of the myosin phosphatase,
and in this way it can indirectly activate NMII (Chu et al., 2012).
Activation by heavy chain phosphorylation
NMII proteins can also be regulated by multiple serine and threonine
phosphorylation sites on the tail domain of the heavy chain, some of which are
specific to individual homologs. The NMIIA heavy chain has a thr-1800, ser-1803
and ser-1808 site in the coiled-coil portion of the tail and a ser-1943 site in the nonhelical tail domain, which is phosphorylated by casein kinase II (Clark et al., 2008).
Absence of this phosphorylation prevents the binding of NMIIA to s100A4, member
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of the s100 family of calcium binding proteins. This results in inhibition of filament
assembly, disrupting its regular function (Dulyaninova and Bresnick, 2013).The
NMIIB heavy chain also has a ser-1937 site phosphorylated by protein kinase C
(PKC), which is responsible for filament assembly (Vicente-Manzanares et al.,
2009). These distinct sites in the two homologs phosphorylated by different
enzymes, but carrying out the same function could indicate a differential regulation
of the NMII proteins at the level of the two heavy chains (Dulyaninova and
Bresnick, 2013).
Inactivation of non-muscle myosin II
Phosphorylation on other sites of the MLC, including ser-1, ser-2 and thr-9 and
dephosphorylation on ser-19 or thr-18 are known to deactivate NMII (Betapudi,
2014; Vicente-Manzanares et al., 2009). A myosin specific enzyme that directly
dephosphorylates the MLC is the myosin phosphatase, which results in
inactivation of the myosin molecule (Ito et al., 2004). Myosin phosphatase has
three subunits- PP1c, MYPT1 and M20. PP1c and M20 interact with the N and C
terminal domains of MYPT1 and affect its function. The PP1 subunit of myosin
phosphatase dephosphorylates the MLC, inactivating the entire myosin molecule
(Fig 7). Mypt1 zebrafish mutants show an abnormal neuroepithelial cell shape
phenotype in the hindbrain, indicating the importance of NMII in brain development
(Gutzman and Sive, 2010). Mypt1 has also been implicated in key developmental
processes involving convergence extension, gastrulation, and dorsal closure
which involve NMII functions (Conti and Adelstein, 2008; Franke et al., 2005;
Heissler and Manstein, 2013).
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Upstream signaling pathways regulating NMII phosphorylation state
Based on the vast literature of the structure and function of NMII isoforms, it is
surprising that it is still not well understood if they function differentially and how
they are differentially activated. Many studies in the last few decades have tried to
tease out the mechanism in which NMII is regulated to carry out its function. The
multiple kinases and phosphatases discussed in the previous section only depict
the regulation of NMII at one level. Upstream of each of these enzymes are multiple
signaling molecules that carry out molecular cross-talk within the cell and
extracellularly. NMII is activated by ROCK mediated phosphorylation of the MLC
(Nakajima and Tanoue, 2010). Shroom3 is a recently identified protein required for
apical constriction in chick and mouse neural tube closure (Nishimura and
Takeichi, 2008). It recruits ROCK to apical cell junctions. Shroom3 mutants and
morphants show reduced accumulation of F-actin and phosphorylated MLC,
indicating its role in regulating NMII (Hildebrand and Soriano, 1999; Nishimura and
Takeichi, 2008). In the same context, the Rho-ROCK signaling axis has been
widely studied for its role in morphogenetic processes that especially involve
cytoskeletal remodeling and cell shape changes (Suzuki et al., 2012). Inhibition of
Rho causes a decrease in phosphorylation of the MLC and leads to defects in
neural tube closure (Kinoshita et al., 2008). Further, the Rho-ROCK axis is known
to be regulated by Wnt and the planar cell polarity (PCP) pathway in vertebrate
cardiac development (Phillips et al., 2005). Calcium mediated regulation of myosin
II has been studied intensely in muscle contraction, and more recently, in nonmuscle cells as well (Szent-Gyorgyi, 1975). Calcium regulates myosin II
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phosphorylation through MLCK in smooth muscle and endothelium (Martinsen et
al., 2013). The JNK pathway also controls NMII localization in fly wound healing
(Kwon et al., 2010). Thus, there are multiple signaling pathways regulating NMII
and we are interested in understanding this regulation during zebrafish midbrainhindbrain boundary morphogenesis. We are specifically interested in the role of
calcium signaling, which will be covered in the next section.

F. CALCIUM SIGNALING PATHWAY
Calcium signaling in development and regulation of cell shape
Calcium has been implicated in early development during various events
(Slusarski and Pelegri, 2007). Waves of calcium are observed in dorsal explants
of Xenopus embryos and inhibition of calcium causes convergence and extension
defects (Wallingford et al., 2001). In zebrafish embryos, intercellular calcium waves
are observed at the margin of gastrulating embryos (Gilland et al., 1999). Calcium
signaling is also important in maintenance of left-right body axis during
development. In zebrafish, cilia in the Kupffer’s vesicle collectively beat in a
coordinated left-sided rotation to produce a calcium gradient that regulates leftright symmetry of visceral organs (McGrath et al., 2003; Sarmah et al., 2005).
Similarly, in chick embryos, left-right axis determination requires extracellular
calcium waves (Raya et al., 2004). Calcium channel blockade causes defects in
organ formation, as seen in heart morphogenesis (Porter et al., 2003). Thus,
calcium is required in many vital developmental processes and could potentially
be important in midbrain-hindbrain boundary morphogenesis.
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Calcium also plays a role in cell shape changes. Regulation of platelet shape has
been widely studied and is regulated by calcium induced phosphorylation of the
MLC (Porter et al., 2003). Calcium entry into the cell through store operated
calcium channels (SOC) causes cell shape changes in pulmonary endothelial cells
by rearrangement of microfilaments (Moore et al., 1998). During wound healing in
the Xenopus ectoderm, cell shape changes at the edge of the wound are disrupted
when calcium levels are pharmacologically altered (Stanisstreet, 1982). Thus, we
hypothesize that calcium may have a critical role in regulation of cell shape
changes that mediate brain morphogenesis.
Overview of the calcium signaling pathway
Calcium signaling pathways are highly versatile and signal to affect various
processes within the cell. Since calcium is not metabolized by the cell, it is stored
inside cells and released when required (Berridge, 1997). A delicate balance of
cytosolic calcium ion concentration is maintained by various channels on the
plasma membrane or membranes of the storage organelles (Duchen, 2000). The
basic mechanism of this pathway is calcium induced calcium release, where an
initial amount of calcium induces the release of greater amounts of calcium from
its intracellular stores, triggering regenerative calcium waves (Berridge et al.,
2000). Apart from calcium entry into cells from the external environment through
channels in the plasma membrane, calcium within the cell can be released from
membrane bound organelles that store calcium which include the endoplasmic
reticulum (ER) and mitochondria (Fig. 8) (Duchen, 2000). A major source of stored
intracellular calcium in non-neural cells is the endoplasmic reticulum, the release
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of Ca2+ ions depends on the opening of specific membrane channels- the
ryanodine (Ryr) receptor channels, SERCA channels or the inositol triphosphate
receptor (IP3R) channels (Putney, 1986). The Ryr receptor channels are
predominantly present in cardiac and skeletal muscles and are regulated by
cytosolic calcium through calcium-induced calcium release (Fill and Copello,
2002). The SERCA channels or the sarco/endoplasmic reticulum Ca 2+-ATPase
channels are exclusive to muscle cells and transport calcium ions from the cytosol
into the sarcoplasmic reticulum (Gomez-Viquez et al., 2003). The opening of the
IP3R channels is stimulated by inositol 1,4,5- triphosphate (IP3) which is a product
of a signaling pathway initiated at the cell membrane through extracellular ligands.
Hormones or growth factors can bind to extracellular receptors such as the
receptor tyrosine kinases (RTK) or G protein coupled receptors (GPCR), activating
phospholipase C (PLC), that converts membrane bound phosphatidylinositol 4, 5
bisphosphate (PIP2) to IP3 and diacylglycerol (DAG) (Slusarski and Pelegri, 2007).
The release of IP3 then allows release of calcium from the ER by stimulation of the
IP3R (Fig. 8). Once released, calcium can act as a secondary messenger and
signal to downstream molecules like troponin C, calmodulin and cyclic AMP
(cAMP) which are calcium dependent proteins that can, in turn signal to various
downstream effectors (Slusarski and Pelegri, 2007).
Unlike other signaling molecules, which are synthesized in the body and are
ultimately products of cellular transcription and translation, calcium, in order to be
able to transmit signals across the cellular system, needs to bind to certain proteins
or kinases that can transmit and induce downstream effects (Yanez et al., 2012).
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Several calcium binding molecules exist such as calmodulin and calcineurin
(Kawasaki et al., 1998). Calcineurin, or protein phosphatase IIB, is activated by
calcium-calmodulin and is a serine/threonine protein phosphatase that links
calcium to phosphorylation states of proteins. Calmodulin is one of the extensively
studied calcium-binding proteins. It is directly affected by the concentration of
intracellular calcium. Interestingly, MLCK is affected by calmodulin levels,
indicating that actomyosins could be potential downstream effectors of calcium
(Van Lierop et al., 2002).
Calcium signaling and regulation of non-muscle myosin II
The role of calcium in regulating myosin has been classically studied in skeletal
muscles with respect to its function in muscle contraction (Szent-Gyorgyi, 1975).
In comparison, the regulation of actomyosins by calcium signaling in non-muscle
models is less studied (Somlyo and Somlyo, 2003). Calcium has been shown to
regulate NMII through MLCK in smooth muscle and endothelium (Martinsen et al.,
2013; Watanabe et al., 2001). However, its regulation of NMII in development and
morphogenetic processes are yet to be determined.
We know that actin filaments in association with their molecular motors, myosins,
drive cell shape changes during developmental processes such as germ band
elongation, mesoderm invagination, dorsal closure and egg chamber elongation
(He et al., 2010; Martin et al., 2009; Rauzi et al., 2010; Solon et al., 2009).
Interestingly, most of these processes are also regulated by calcium signaling. For
example, in the zebrafish embryo, at 75% epiboly, an actomyosin ring is formed
along the margin and an increased amount of calcium is observed at the margin
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during the epiboly stages (Popgeorgiev et al., 2011). We also know that NMII
phosphorylation is carried out by MLCK, and it has been shown that the activation
of MLCK is required for epiboly to progress (Popgeorgiev et al., 2011). Additionally,
in the zebrafish embryo, misexpression of cAMP response element binding protein
(CREB) causes defects in MHB morphogenesis (Dworkin et al., 2007). cAMP,
being a common second messenger in the calcium signaling pathway, suggests
possible calcium regulation of NMII in MHB formation (Dworkin et al., 2007;
Dworkin and Jane, 2013).
In the current research, we have studied the role of NMII and its regulation by
calcium signaling during MHB morphogenesis in zebrafish. We discover that
NMIIA regulates cell length while NMIIB regulates cell width during MHB formation
in zebrafish. We further find that calcium is required in this process, and that it
specifically regulates MHBC cell length. These and future findings will be important
in expanding our knowledge of the mechanisms of other similar developmental
processes as well.
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Figure 1. Schematic showing early brain development and morphogenesis.
(A) Brain is derived from the ectoderm which folds to form the neural tube by the
process of neurulation. (B) The neural tube undergoes morphogenesis to form the
future forebrain, midbrain and hindbrain. The midbrain-hindbrain boundary
constriction (MHBC) is a distinct visible fold (red arrowheads). The neural tube
develops and differentiates to eventually form the complex adult brain. F,
Forebrain; M, Midbrain; and H, Hindbrain.
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Figure 2. Midbrain-hindbrain boundary formation in zebrafish. (A-D)
Brightfield dorsal images of zebrafish embryos showing midbrain-hindbrain
boundary formation at (A) 18 hpf or 18 ss, (B) 20 hpf or 22 ss, (C) 22 hpf or 24 ss
and (D) 24 hpf or prim-6. (A’-D’) Enlarged images of boxed regions in A-D.
Embryos are oriented anterior to the left and posterior to the right. Hpf, hours post
fertilization; ss: somite stage; M, midbrain; H, hindbrain.
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Figure 3. Schematic showing various cell shape changes that can occur in
an epithelial tissue during morphogenesis. (A) cell elongation, (B) cell
shortening, (C) flattening, (D) apical constriction, and (E) basal constriction.
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Figure 4. Schematic showing various cellular factors that can affect
morphogenesis. 1. Specific gene expression is initiated in the nucleus and mRNA
is transcribed and then translated to produce functional proteins. 2. Intracellular
proteins and extracellular ligands signal to intermediate molecules. 3. Mechanical
forces generated by cytoskeletal elements- (3a) microfilaments and (3b)
microtubules ultimately carry out specific cell shape changes resulting in
morphogenesis.
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Figure 5. Non-muscle myosin II structure. Diagram of the basic structure of
non-muscle myosin II proteins showing the heavy and light chains along with the
head, neck and tail domains.
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Figure 6. Non-muscle myosin II genes. Schematic showing the different nonmuscle myosin II (NMII) homologs- NMIIA, NMIIB and NMIIC, encoded by their
respective genes- MYH9, MYH10 and MYH14. Corresponding analogous genes
in the zebrafish are also shown.
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Figure 7. Regulation of the phosphorylation state of non-muscle myosin II.
Schematic showing activation of non-muscle myosin II by phosphorylation of the
regulatory light chain by myosin light chain kinase and dephosphorylation by
myosin phosphatase. Shown in grey are various other kinases that also regulate
the phosphorylation state of non-muscle myosin II molecules. DAPK, Death
Associated Protein Kinase; ZIPK, Leucine Zipper interacting kinase; MRCK,
Myotonic Dystrophy kinase related CDC42-binding Kinase; ROCK, Rhoassociated coiled-coiled kinase; PKC, Protein Kinase C; P, phosphate molecule.
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Figure 8. Schematic representing the proposed hypothesis. Diagram
representing the hypothesis that calcium signals to regulate non-muscle myosin II
by phosphorylation of the myosin light chain. A major source of intracellular
calcium is the endoplasmic reticulum (ER). Calcium is released by the opening of
the IP3R channels on the ER membrane. Red arrow indicates hypothesized
interaction.
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CHAPTER 2
NON-MUSCLE MYOSIN IIA AND IIB DIFFERENTIALLY
REGULATE CELL SHAPE CHANGES DURING
ZEBRAFISH BRAIN MORPHOGENESIS
*THIS CHAPTER HAS BEEN ADAPTED FROM:
Jennifer H. Gutzman, Srishti U. Sahu, Constance Kwas
Developmental Biology, Volume 397, Issue 1, 1 January 2015, Pages 103–115
Contributions: Work performed by Srishti Sahu includes partial contribution to
Figures 9-13, S1, S3 and sole contribution to Figure S4.

A. INTRODUCTION
Morphogenesis is a key developmental process that shapes all organs and is
required for proper organ function. Regulation of individual cell shape changes are
at the core of morphogenetic events which together give rise to whole tissue shape
(Heisenberg and Bellaiche, 2013; Lecuit and Lenne, 2007). During vertebrate brain
development, neuroepithelial cells of the neural tube fold in specific regions giving
rise to the characteristic embryonic vertebrate brain shape. The fold at the
midbrain-hindbrain boundary (MHB) functions as a crucial organizing center for the
developing embryo and is one of the earliest and most highly conserved folds in
the vertebrate brain (Brand et al., 1996; Rhinn and Brand, 2001). Given the high
degree of conservation of the MHB across vertebrate species in terms of function
and form, understanding the molecular mechanisms underlying its development is
critical to our understanding of brain morphogenesis.
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Our previous work characterized the basic morphogenetic events that occur to
form this highly conserved fold in the zebrafish. We demonstrated that cell
shortening and basal constriction occur in cells at the point of deepest constriction
of the MHB, the midbrain-hindbrain boundary constriction (MHBC) (Gutzman et al.,
2008). While we previously determined that basal constriction is dependent on
laminin, the mechanisms that regulate cell shortening at the MHBC are unknown.
Neuroepithelial cell shape and brain morphogenesis are also dependent upon the
contractile state of the neuroepithelium (Gutzman and Sive, 2010). This contractile
state is tightly regulated by non-muscle myosin II (NMII) activity. We demonstrated
that mypt1, the myosin phosphatase regulatory subunit, is required for cell shape
regulation during hindbrain morphogenesis and important for regulating the activity
of NMII (Gutzman and Sive, 2010). Myosin phosphatase dephosphorylates the
myosin regulatory light chain (MRLC) where MRLC, in the phosphorylated state,
activates the contraction of NMII. NMII proteins are critical regulators of cell
motility, cytokinesis, polarity, and adhesion. In addition, it has been established in
multiple systems, that cell shape is critically dependent upon NMII function
(Vicente-Manzanares et al., 2009).
Depending on the tissue and cell type, NMIIA and NMIIB may have either
overlapping or distinct roles during embryonic development (Wang et al., 2011).
For example, NMIIA and NMIIB knockout mice have different phenotypes. NMIIA
knockouts are embryonic lethal and die before gastrulation due to defects in cellcell adhesion (Conti et al., 2004). In contrast, NMIIB knockout mice display heart
defects, hydrocephalus, and abnormal neuronal migration (Ma et al., 2007; Ma et
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al., 2004). In migrating cells, NMIIA and NMIIB have different localization and
function, which depends on the rigidity of the specific migratory substrate (Raab et
al., 2012).
Given that non-muscle myosins have important roles in regulating cell and tissue
shape, we hypothesized that NMIIA and NMIIB regulate cell shape changes that
occur to form the MHBC. Here we used the zebrafish MHB as a model for
determining the molecular mechanisms regulating the initial cell shape changes
that occur during brain morphogenesis. We discovered distinct roles for NMIIA and
NMIIB in MHB morphogenesis using live imaging to quantify changes in cell shape.
We determined that NMIIA controls the length of the cells specifically at the MHBC,
while NMIIB regulates the width of cells throughout the MHB tissue. Thus NMIIA
and NMIIB perform non-redundant functions in regulating the morphogenesis of
the MHB.

B. MATERIALS AND METHODS
Zebrafish maintenance and husbandry
Standard procedures were used for zebrafish maintenance and husbandry
(Kimmel et al., 1995; Westerfield, 2000). Wild-type AB zebrafish embryos were
used for all experiments. Embryos were staged according to Kimmel et al., 1995.
For all experiments somite number was counted to allow for consistent staging
comparisons and to eliminate the possibility of phenotypes resulting from
developmental delay. The following equivalent staging points were used; 18 somite
stage (ss) is equal to 18 hours post fertilization (hpf); 22 ss is equal to 20 hpf; and
24 ss is equal to 22 hpf.
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Embryonic gene expression analysis
For all of our studies we used the following sequence information from Zebrafish
Ensembl (Flicek et al., 2013). myh9a located on the reverse strand of
chromosome 6, ENSDART00000149823. myh9b located on the reverse strand of
chromosome 3, ENSDART00000137105. myh10 homolog was found to be
located on the forward strand of a different region of chromosome 6,
ENSDART00000151114. RT-PCR was conducted on RNA isolated from wildtype embryos over time. Primers used include:
myh9a forward primer (5’-AAATTCAGCAAGGTGGAGGA-3’);
myh9a reverse primer (5’-TTGGTGTTTTCGGTTTTTCC-3’);
myh9b forward primer: (5’-CCTGCCCATCTACTCAGAGG-3’);
myh9b reverse primer (5’-TGTGGAAGGTTCGCTCTTCT-3’);
myh10 forward primer (5’-CTTCTGAACGGCATGGATTT-3’);
myh10 reverse primer (5’-TTGGCATTTCCAAAGGATTC-3’);
Ef1α forward primer (5’-GATGCACCACGAGTCTCTGA-3’);
Ef1α reverse primer (5’-TGATGACCTGAGCGTTGAAG-3’).
Antisense morpholino oligonucleotide injections
Splice site-blocking morpholino antisense oligonucleotides (morpholino: MO) were
used for all knockdown experiments. MO details for each gene are as follows:
myh9a MO (5’-AGCAAGAGAGACTTACAAATCGAGA-3’; Gene Tools) that
targets intron1-EXON2. myh9b MO (5’-ATGTCTGAAACAGTCGTTTACAA GC-3’;
Gene Tools) that targets EXON6-intron6. myh10 MO (5’-CTTCACAAAT
GTGGTCTTACCTTGA-3’; Gene Tools) that targets EXON2-intron2. mypt1 MO
(5′-ATTTTTTGTGACTTACTCAGCGATG-3′; Gene Tools) that targets exon 2intron

2

(Gutzman

and

Sive,

2010).

Standard

control

MO

(5′-
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CCTCTTACCTCAGTTACAATTTATA-3′) was used were indicated (Gene Tools).
Zebrafish p53 MO (5’-GCGCCATTGCTTTTGCAAGAATTG-3’; Gene Tools) was
only used in conjunction with the myh9b MO (Robu et al., 2007). For all MO
knockdown experiments, the following concentrations were used and injected into
one cell stage embryos either alone or in conjunction with membrane targeting
GFP (mGFP). 4ng myh9a MO, 3 ng myh9b MO with 3ng p53 MO, 3ng myh10 MO,
5ng mypt1 MO. The concentration of control MO was equal to the highest
concentration of any experimental MO used in that experiment. Up to 6ng of myh9a
MO was used with no obvious brain phenotype. All confocal evaluation for myh9a
MO was conducted at 4ng.
In situ hybridization
In situ hybridization was conducted according to standard procedures. RNA probes
were designed to unique UTR sequences due to the high sequence similarities in
the coding regions of these genes (probe regions are shown in Fig. 9). The myh9a
probe was cloned from the 3’end into the 3’ UTR of myh9a from 24 hpf wild type
embryos using the following primers. myh9a primer 3’end forward (5’TGGAGGAGACTGAGGAGGAA-3’),

myh9a

primer

3’UTR

reverse

(5’-

GAACAGGCCGAATGAAACAT-3’) resulting in a 502 bp probe. The myh9b in situ
probe was cloned from the 5’UTR into the 5’end of myh9b from 24 hpf wild type
embryos using the following primers. myh9b primer 5’UTR forward (5’GTGGAAGAGGGAGGGAAGAG-3’),

myh9b

primer

5’end

reverse

(5’-

AAGGCACCCACACTAGCTTC-3’) resulting in a 290 bp probe. The PCR
fragments above were subcloned into pGEM using the pGEM T-Easy Vector
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System Kit (Promega) for probe synthesis. The myh10 in situ probe was made
from Image clone 8801976 from Open Biosystems and is located in the 3’UTR of
the gene and results in an 810 bp probe. Sense and antisense probes were made
and used for each in situ experiment to test for specificity.
Actin staining
Embryos were fixed in 4% paraformaldehyde for 2 h at room temperature or
overnight at 4 °C and washed in PBT. Embryos were incubated at 4 °C overnight
in Alexa Fluor 488 phalloidin (Invitrogen A12379) 1:40 in PBT, washed 3X in PBT,
mounted in glycerol, and imaged using a Nikon CS2 laser-scanning confocal
microscope. Images were analyzed with Nikon Elements software and Photoshop
(Adobe).
Non-muscle myosin IIA and IIB immunostaining
Embryos were fixed in Dents for 2 h at room temperature, deyolked, blocked
overnight at 4 °C, and then washed in PBT. Embryos were incubated in primary
antibody (anti-myosin IIA antibody raised in rabbit, Sigma-Aldrich , M8064, 1:500;
and anti-myosin IIB antibody raised in mouse, Santa Cruz Biotechnology, sc376942, 1:100) overnight at 4 °C, washed in PBT, then incubated in secondary
antibody (Alexa Fluor 488 goat anti-rabbit, Life Technologies, 1:500 and/or Alexa
Fluor 555 goat anti-mouse, Life Technologies, 1:500). Embryos were flat mounted
in glycerol, imaged using a Nikon CS2 laser-scanning confocal microscope, and
images were analyzed with Nikon elements and Photoshop (Adobe) software.
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Imaging
All live confocal imaging was conducted as previously described (Graeden and
Sive, 2009) using a Nikon CS2 scanning confocal and Nikon Elements software.
Briefly, embryos were co-injected at the one-cell stage with membrane GFP
(mGFP) mRNA (GFP-CAXX) and the morpholinos indicated. Live embryos were
then mounted in agarose wells on a slide and oriented for imaging. A z-series of
images was taken for each embryo. Live confocal images presented in each figure
are single slices taken from a z-series of images approximately 15-20 microns into
the tissue from the dorsal surface. Brightfield and in situ hybridization imaging was
conducted using an Olympus SZX12 stereomicroscope with an Olympus DP72
camera. All images were processed using Nikon Elements software or Photoshop
(Adobe).
Cell Shape Analysis
For all cell measurements, single cells were selected based on the ability to see
one single cell spanning the entire width of the neuroepithelium from apical to basal
in a single z-plane in the region of interest. Cell length was determined using the
Nikon Imaging Systems (NIS) Elements software measurement tool by measuring
from apical to basal of a single cell spanning the neuroepithelium. The cell width
measurement was obtained from the NIS-Elements software as an average width
of a cell. Single cells were manually outlined in a single z-series image to create
an object. Then the NIS-Elements software determined the average width of the
object (cell) by first calculating the area and the perimeter of the object (cell). The
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software then calculated the length of the object using the formula: Length
= (Perimeter + Sqrt (Perimeter2 – 16*Area))/4. The width of the object was in
turn calculated using the formula: Width = Area/Length.
Statistical Analysis
Statistical analysis for comparisons between all treatment groups was carried out
by ANOVA. For significant results by ANOVA, further t-tests were performed to
determine significance between control treatment and experimental treatment
groups. p-values for t-test comparisons are presented in each figure legend. All
analysis was computed using R-3.0.1.

C. RESULTS
Expression of non-muscle myosin IIA and IIB during embryonic development
Non-muscle myosins are known to be key regulators of cell shape during
embryonic morphogenesis (Lecuit and Lenne, 2007; Vicente-Manzanares et al.,
2009). We hypothesized that these proteins also play an integral role in shaping
the cells that contribute to the MHB tissue fold. In order to test this hypothesis we
first determined the zebrafish homologs of human non-muscle myosin II proteins.
Zebrafish have two homologs of human MYH9 (myh9a and myh9b) encoding for
NMIIA, one homolog for MYH10 (myh10) which encodes for NMIIB, and one
homolog for MYH14 (myh14), which encodes for NMIIC. According to the current
zebrafish genome assembly, the sequence homology for myh9a and myh9b is
77% and 79% respectively, compared to the human MYH9 (Flicek et al., 2013).
Zebrafish myh10 is 90% similar to the human homolog, while myh14 is only 62%
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similar to the human homolog. It has been demonstrated in the mouse that all three
isoforms are expressed broadly throughout the embryo; however, there are tissues
that express relatively higher levels of one isoform compared to others (Golomb et
al., 2004). myh14 appears to have the lowest expression level in the developing
mouse brain (Golomb et al., 2004), and has the lowest sequence homology from
human to zebrafish; therefore, we did not investigate the role of NMIIC in cell shape
changes during MHB morphogenesis in the zebrafish.
Diagrams of the three zebrafish genes investigated in this study are shown (Fig.
9A). Using RT-PCR we confirmed that all three genes were expressed
embryonically during the time of MHB development (Fig. 9B). We further analyzed
gene expression using in situ hybridization to determine the localization of
expression within the developing embryo (Fig. 9C). We found low levels of
expression for myh9a maternally (4 hpf) and at early stages (12 hpf). There was
some localized expression of myh9a within the forebrain, eyes, and tail between
18 and 24 hpf. Non-specific staining for myh9a was detected within the brain
ventricle space and in the yolk in both antisense and sense controls. myh9a did
not have obvious expression in the neuroepithelium of the MHB region during
morphogenesis. myh9b was found to be expressed maternally (4hpf) and
expression was detected throughout the whole embryo and brain at each time
point analyzed. myh10 had a low level of maternal expression at 4 hpf; however,
by 12 hpf myh10 was also found to be expressed throughout the whole embryo
and brain. Together these data indicate that the zebrafish non-muscle myosin II
genes myh9b and myh10 are expressed during the time of MHB morphogenesis
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and are found throughout the embryo and brain. While myh9a is also expressed,
it does not appear to be as highly localized to the brain or MHB region as myh9b
or myh10 at these times. These data are consistent with the reported expression
patterns for myh9 and myh10 during mouse embryonic development (Golomb et
al., 2004). Next, we investigated the role for myh9a, myh9b, and myh10 in
regulating the cell shape changes that are required for the formation of the MHB
fold.
Characterization of early MHB morphogenesis and cell shape changes
In order to better characterize the initial tissue and cell shape changes that lead to
the MHB tissue fold, we performed detailed analysis of wild type MHB development
during early stages of MHB formation when cells are shortening (Gutzman et al.,
2008). We injected wild type embryos with membrane GFP (mGFP) mRNA and
imaged the developing MHB in live embryos using scanning confocal microscopy
at the somite stages indicated (Fig. 10). We quantified changes in the tissue over
this time frame by analyzing tissue angle, cell length, and cell width. We found that
the angle of the fold changes from 140 degrees to less than 100 degrees between
18 and 24 somite stage (ss) (Fig. 10A-D). We found that cells at the MHBC shorten
from 50 microns to less than 40 microns during this time frame (Fig. 10E). We also
found that cells outside the MHBC get slightly shorter during this time; however,
there is still a large difference in cell length at the MHBC compared to cells outside
(Fig. 10F). By 24 ss cells at the MHBC are approximately 75% of the length of the
outside cells (Fig. 10G) which is consistent with our previous findings (Gutzman et
al., 2008). Importantly, we also discovered that the width of the cells changes
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between 22 and 24 ss (Fig. 10H) and cells in the MHB region get narrower as the
morphology of the MHB is changing and the MHBC is forming.
myh9b and myh10 are required for MHB development
In order to define the role for NMIIA and NMIIB in embryonic MHB morphogenesis,
we conducted knockdown experiments using splice-site targeting, antisense
oligonucleotide morpholino (MO) knockdown of myh9a, myh9b, and myh10. Splice
targeting morpholinos were chosen due to the essential requirement for nonmuscle myosins during early development and cell division (Conti et al., 2004; Ma
et al., 2007; Maciver, 1996; Urven et al., 2006). We were able to carefully titrate
the concentration of each splice targeting morpholino to prevent abnormal levels
of cell death while maintaining normal levels of cells division, which allowed us to
determine the role for these proteins in regulating cell shape during
morphogenesis. Splice blocking morpholinos were confirmed at the concentrations
used for all of the experiments presented here using RT-PCR or Western blot
analysis (Fig. S1).
Embryos were injected with morpholinos at the one-cell stage and analyzed for
gross embryonic phenotypes and for overall brain morphology at 24 ss using
brightfield microscopy. Although we focused specifically on brain morphogenesis
defects and cell shape changes at the MHB for this study, we did observe other
gross phenotypes in morpholino injected embryos (Fig. S2). myh9b morphants
demonstrated somite defects, abnormal tail curvature, pigmentation defects, heart
abnormalities, slight edema, and abnormal eye and ear formation. myh10
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morphants had abnormal body axis curvature, heart abnormalities, and abnormal
eye development. myh9a morphants injected with our splice site targeting MO did
not appear to have any observable gross morphology defects with the
concentrations of morpholino tested (Fig. S2). This is in contrast to the studies by
Muller et al. where they demonstrated that knockdown of myh9a (previously called
zmyh9 and myh9-like2) using a MO targeting the 5’-untranslated region and
translational start site, leads to abnormal development of the glomerulus and
causes gross embryonic edema at 5 days post fertilization (Muller et al., 2011). In
those studies Muller et al. did not investigate the role of the other zebrafish myh9
gene, myh9b (previously called myhz9 and myh9-like1). This difference in overall
gross phenotype for myh9a knockdown between our studies and Muller et al. is
likely due to the timing of phenotypic analysis, the nature of the morpholinos
utilized, and their respective target sequences.
Analysis of overall MHB morphology in control MO injected embryos at 24 ss
showed normal formation of the MHB, visible with a clear and distinct fold in the
tissue at the point of deepest constriction (MHBC) and normal openings in the
midbrain and hindbrain ventricles (Fig. 11A). These results are consistent with our
previous reports (Gutzman et al., 2008). A morpholino designed specifically to
target only myh9a did not result in any visible abnormal MHB or brain phenotype
when imaged with brightfield microscopy (Fig. 11B). In contrast, embryos injected
with the myh9b MO or the myh10 MO had abnormal MHB development. myh9b
morphants did not have a sharp fold in the tissue at the point of deepest
constriction, instead the fold was a curved shape (Fig. 11C). myh10 morphants,
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similar to myh9b morphants, failed to form a sharp tissue bend at the MHB (Fig.
11D). myh10 morphants also had decreased midbrain ventricle opening (Fig. 11D).
We have previously shown that abnormal brain ventricle inflation, due to lack of
cerebrospinal fluid as found in the snakehead mutant, did not affect cell shape at
the MHB (Gutzman et al., 2008). Therefore, the myh10 morphant ventricle defect
is likely due to abnormal dorsolateral hinge-point formation which is also
dependent on non-muscle myosin II (Nyholm et al., 2009). Knockdown of both
myh9a and myh9b together, or myh9a and myh10 together, at the same
concentration of morpholino used for single knockdown, did not worsen or change
the MHB phenotype observed (data not shown). However, the double knockdown
of myh9a and myh9b did appear to worsen the gross whole embryo tail and eye
phenotypes at 24 ss, which is consistent with the localization of myh9a gene
expression at this time point (data not shown).
We rescued the 24 ss brain phenotypes in myh9b and myh10 morphants by coinjection of human MYH9 or MYH10 mRNA (Fig. S3). Quantification and
representative images are shown for normal, mild, and severe myh9b and myh10
morphant phenotypes (Fig. S3). For all of the experiments presented here
investigating MHB defects and cell shape analysis, only mild phenotypes were
analyzed. This is consistent with the level of protein knockdown we detect using
the myh10 morpholino, where our knockdown results in approximately 40% loss
of the NMIIB protein (Fig. S1D). Together these data demonstrate that knockdown
of both myh9b and myh10, but not myh9a knockdown, results in abnormal
formation of the MHB indicating a role for myh9b and myh10 in brain
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morphogenesis. More detailed and quantitative comparisons of the knockdown
MHB phenotypes are described in the following sections.
MHB tissue angle is dependent upon non-muscle myosin IIA and IIB
After determining that knockdown for both myh9b and myh10 led to defects in MHB
formation by brightfield microscopy, we wanted to determine the specific role for
these non-muscle myosin proteins in regulating cell and tissue shape during
morphogenesis. We performed detailed analyses on our non-muscle myosin II
morphant brains and compared them to control morpholino injected embryos. We
first examined the MHB tissue angle. Single-cell embryos were injected with MO
and mGFP, and then imaged live using confocal microscopy. The angle at the
MHBC was measured and compared (Fig. 11E-J). The average angle at 24 ss in
control MO injected embryos was approximately 100 degrees. myh9a morphants
had a normal tissue angle; however, myh9b MO injected embryos had a broader
tissue angle of 125 degrees, and myh10 MO injected embryos had an abnormal
MHB tissue angle of 140 degrees (Fig. 11E-J). These results indicate that both
myh9b and myh10 contribute to the formation of the tissue angle at the MHB. We
also analyzed the tissue angle in mypt1 morphants. mypt1 is the regulatory subunit
of myosin phosphatase and mypt1 knockdown results in non-functional myosin
phosphatase and overactive non-muscle myosin II activity (Hartshorne et al.,
2004). In addition, our previous report demonstrated that mypt1 knockdown leads
to abnormal tissue and cell shape in the hindbrain (Gutzman and Sive, 2010). With
mypt1 knockdown, and therefore overactive NMIIA and NMIIB, we found that the
mypt1 morphants also had an abnormal tissue angle with an average of 130
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degrees at 24 ss (Fig. 11I-J). This result further supports the observation that
regulation of non-muscle myosin activity is important for this morphogenetic
process.
Since non-muscle myosin II is known to be required for normal cell proliferation,
we confirmed that the brain phenotypes observed were not a result of increased
or decreased cell proliferation or cell death. We analyzed cell proliferation with PH3
staining and cell death with TUNEL staining. We found that cell proliferation and
cell death were normal in myh9b and myh10 morphants at the concentrations of
MO used for these experiments (Fig. S4). Together, these results indicate that
myh9b and myh10 have critical roles in determining the proper angle of tissue
folding at the MHB, and that myh9a does not appear to be involved in this process.
The mypt1 knockdown phenotype also confirms the importance of specific
regulation of the contractile state of the NMII proteins during MHB morphogenesis.
myh9b is required for cell shortening at the MHBC
During MHB morphogenesis, the first cell shape change occurs between 17 and
22 hours post fertilization (equivalent to 16 to 24 ss) where cells at the MHBC
shorten to 75% of the length of cells outside of the MHBC (Fig. 10 and (Gutzman
et al., 2008). The mechanisms that regulate cell shortening at the MHBC are
unknown. We hypothesized that NMII proteins regulate this cell shape change
which is required for the formation of the normal MHB tissue angle. We tested this
hypothesis using knockdown experiments and then quantifying the length of the
cells at the MHBC and outside of the MHBC (Fig. 12). Embryos were injected with
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mGFP and specific morpholinos targeting myh9a, myh9b, myh10, or mypt1, and
then live imaged at 24 ss using confocal microscopy. Cell length was quantified at
the MHBC. At this stage of development neuroepithelial cells span the entire
epithelium from apical to basal; therefore, we used the width of the single layer of
pseudostratified epithelium as a measure of cell length. We measured cell length
on one side of the neural tube at the MHBC (X) (Fig. 12A). Then we measured the
length of cells 40 microns posterior to the MHBC (approximately 15 cells) outside
of the MHBC region (Y) (Fig. 12B). We found that myh9b morphants had
significantly longer cells at the MHBC compared to controls, while the length of the
MHBC cells in myh9a and myh10 morphant cells were unchanged (Fig. 12C-G).
In the surrounding region posterior to the MHBC we found that cell length in myh9b
morphants was the same as control, but myh10 cells were slightly, but significantly,
shorter (Fig. 12H). However, this small change in cell length outside of the MHBC
from myh10 morphants would still not account for the dramatic angle change
observed at the MHBC.
At the MHBC, and outside of the MHBC, mypt1 morphant cells were shorter than
control cells (Fig. 12F, H). This observation continues to support the role for mypt1
in regulating myosin contraction. mypt1 morphants have overactive myosin, which
causes increasing actomyosin contraction within the cells and leads to a
shortening of the cells, consistent with the cell shape phenotype previously
observed in the hindbrain (Gutzman and Sive, 2010).
Together these data indicate that cell shortening at the MHBC is dependent upon
the function of myh9b, and not myh10, suggesting a different role for these two
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non-muscle myosin proteins in regulating cell shape changes during MHB
morphogenesis.
myh10 is required for regulating cell width in the MHB
In our detailed analysis of wild type embryos we discovered that cells throughout
the MHB region become narrower during the formation of the fold (Fig. 10). While
conducting our knockdown experiments and confocal imaging, we noticed that
cells of the MHB in some morpholino-injected embryos looked wider than in
control-injected embryos. Therefore, we conducted additional quantification of cell
shapes by determining cell width and area in the MHB neuroepithelium in
knockdown embryos. Embryos were injected with mGFP and morpholinos, and
then live imaged at 24 ss using confocal microscopy. We quantified cell width and
cell area in cells at the MHBC and in the posterior part of the MHB (Fig. 13). We
found that cells in the myh9a and myh9b morphants had normal cell width and
area (Fig. 13A-C, F, G); however, cells from embryos injected with myh10
morpholino had significantly increased cell width and area (Fig. 13D, F, G). mypt1
morphants also had significant differences in cell area and width (Fig. 13E-G) as
would be predicted by over activation of non-muscle myosin and as previously
observed in the hindbrain (Gutzman and Sive, 2010).
These data indicate that myh10, and not myh9b, is critical for the regulation and
maintenance of cell width in the MHB region of the neuroepithelium. This further
supports the differential role for myh9b and myh10 in regulating cell shape at the
MHB.
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Abnormal distribution of actin at the MHB with NMIIA and NMIIB knockdown
The discovery that NMIIA and NMIIB have different roles in regulating cell shape
changes at the MHB led us to ask, what are the mechanisms for this differential
regulation? We have previously demonstrated that later in MHB formation (24 hpf)
actin is enriched at the MHBC (Gutzman et al., 2008), and since we know that nonmuscle myosin proteins are actin motors, we asked whether or not the distribution
of actin in our knockdown embryos was also differentially disrupted with NMIIA or
NMIIB knockdown.
Embryos were injected with the morpholino indicated, stained with phalloidin, and
imaged using confocal microscopy to show actin localization in the MHB region
(Fig. 14). We quantified the relative distribution of actin within the MHB in three
regions. We determined the amount of actin within the neuroepithelium at the
MHBC compared to the neuroepithelium outside the MHBC (Fig. 14A). We
compared the amount of actin located apically at the midline of the neural tube
compared to the amount of actin within the neuroepithelium at the apical edge of
the MHBC cells (Fig. 14B), and we compared the amount of actin located on the
basal side of the neural tube compared to the amount of actin within the
neuroepithelium at the basal edge of the MHBC cells (Fig. 14C). These different
regions of the neuroepithelium were used for comparison in B and C to more
carefully address changes at the extreme apical or basal edges of the cells
compared to just inside the adjacent neuroepithelium. We used the ratio of mean
fluorescence intensity of actin staining in two regions within each embryo for
comparison, shown by box 1 and box 2 (Fig. 14A-C). The actin mean intensity ratio
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for box 1 was divided by box 2 in that given region. A ratio of 1 would indicate equal
distribution of actin in box 1 and box 2. In control embryos there is approximately
1.5 times more actin within the neuroepithelium at the MHBC compared to more
posterior neuroepithelium. This reflects the actin distribution previously described
(Gutzman et al., 2008). There is 2 times more actin localized to the apical region
of cells compared to the adjacent apical side of the neuroepithelial cells, and there
is 1.5 times more actin on the basal side of the epithelium compared to the adjacent
basal side of the neuroepithelium in the region of the MHBC (Fig. 14A-C, G). When
we investigated actin distribution with myh9b knockdown we found a decrease in
actin localization within the MHBC neuroepithelium and apically, while basal actin
was unchanged (Fig. 14D, G). With myh10 knockdown there was a significant
decrease in actin localized to the MHBC neuroepithelium, apically, and basally
indicating that actin in all areas of the MHBC cells was disrupted (Fig. 14E, G).
mypt1 knockdown did not affect apical actin distribution, as previously reported in
the hindbrain (Gutzman and Sive, 2010); however, actin within the MHBC
neuroepithelium was disrupted, as was basal actin distribution (Fig. 14F-G).
Together, the differences in actin distribution with myh9b knockdown compared to
myh10 knockdown are consistent with myh9b and myh10 having differential effects
on regulating the actin cytoskeleton and neuroepithelial cell shape changes at the
MHBC. myh9b affected actin only in the neuroepithelium and apically at the
midline, while myh10 affected actin within the neuroepithelium, apically, and
basally.
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Non-muscle myosin IIA and IIB protein localization
We also hypothesized that NMIIA and NMIIB would be differentially localized within
the cells which could in turn explain their ability to differentially regulate cell shape.
In order to test this hypothesis we used antibody staining specific for either NMIIA
or NMIIB to see their localization pattern within the MHB region (Fig. 15). We did
not detect any obvious differences between NMIIA and NMIIB localization in
control embryos (Fig. 15A-C). The localization pattern was consistent with what
has been demonstrated in the mouse neural tube (Ma et al., 2007). We did,
however, see changes in both NMIIA and NMIIB localization with mypt1
knockdown where non-muscle myosin II proteins accumulated apically and basally
in the neuroepithelium as seen previously for NMIIA (Fig. 15D and (Gutzman and
Sive, 2010)). Interestingly, when we stained for NMIIA with knockdown of myh10
we found a change in NMIIA localization from generally cytoplasmic and apical to
more diffuse and basally localized (Fig. 15E). We also found a change in NMIIB
localization with myh9b knockdown, again from mostly cytoplasmic to more diffuse
with increased basal localization (Fig. 15F). No primary controls are shown to
indicate the specificity of the staining (Fig. 15G-H).
These data indicate that normally, the localization of NMIIA and NMIIB is
overlapping within the neuroepithelium of the MHB region at this time, suggesting
that the mechanism by which NMIIA and NMIIB are differentially regulating cell
shape changes during brain morphogenesis is not due to differential localization,
but likely due to differential regulation of activity. Furthermore, our analysis of
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localization of one NMII protein with knockdown of other indicates that NMIIA and
NMIIB depend on each other for proper localization.

D. DISCUSSION
myh9b

and myh10

differentially regulate

cell

shape

during

MHB

morphogenesis
In wild type embryos, the basal angle of the MHB changes over time from 140
degrees at 18 ss to a more acute angle of 95 degrees by 24 ss (Fig. 10). During
this time, cells at the MHBC are changing shape to allow this angle to form. Cells
at the MHBC shorten by approximately 25%, while cells outside the MHBC also
shorten slightly over this time window (Fig. 10). Concurrently, cells throughout the
MHB region become narrower between 22 ss and 24 ss (Fig. 10). Together these
morphogenetic changes lead to the formation of the highly conserved MHB fold
(Fig. 16A).
Here, we demonstrate for the first time that non-muscle myosin IIA and IIB have
distinct roles in regulating cell shape changes during brain morphogenesis. We
discovered that NMIIA is required for the shortening of the cells specifically at the
MHBC, while NMIIB is required for the narrowing of the cells throughout the MHB
region (Fig. 16B and C). In contrast to our knockdown studies, we investigated
non-muscle myosin II gain of function using mypt1 knockdown. We found that cells
in mypt1 morphants, where there is over activation of non-muscle myosins, were
both shorter and wider cells throughout the MHB region (Fig. 16D), which is
consistent with the cell shape phenotype found with mypt1 loss of function in the
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hindbrain (Gutzman and Sive, 2010). Together, these data demonstrate that NMIIA
is required for regulating the length of cells specifically at the MHBC and not in
surrounding regions, while NMIIB is required for regulation of cell width throughout
the MHB region. This uncovers a novel differential role for mechanisms by which
these two proteins regulate cell shape during brain morphogenesis.
Cell length and cell width during development
Morphogenetic processes require specific changes in cell shape to cause bending
of epithelial sheets, tissue invagination, and tube formation. We propose that
regulating cell length and cell width may be as important in developmental
processes as apical constriction or cell migration; however, investigation and
quantification of these more subtle changes in cell shape has been limited. Apical
constriction results in decreased surface area on the apical side of the polarized
cell changing shape, and is critical in development during gastrulation and
vertebrate neural tube formation (Haigo et al., 2003; Lee and Harland, 2007; Martin
et al., 2009). Various mechanisms of apical constriction have been described
depending on cell type and context, typically involving apical actomyosin networks
linked to cell-cell apical junctions (Martin and Goldstein, 2014). Other cell shape
changes including changes in cell length, width, or basal constriction have been
less well defined and are likely to be regulated via both overlapping and distinct
mechanisms. For example, during neural tube formation, cells of the neural plate
have been described to lengthen before they apically constrict (Karfunkel, 1974),
and although this cell shape change has been defined for decades, the mechanism
for this cell lengthening has not been studied. Distinct mechanisms have been
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uncovered for regulation of basal constriction. We determined that basal
constriction at the MHB, following cell shortening, is laminin dependent, and basal
constriction in optic cup morphogenesis requires the novel gene ojoplano
(Gutzman et al., 2008; Martinez-Morales et al., 2009; Wang et al., 2012). In
contrast, follicle cells in drosophila egg chamber elongation are regulated by
actomyosin contraction, as in apical constriction; however, the orientation of the
filaments is different and the contraction occurs basally, not apically, to shape the
tissue (He et al., 2010).
The Kupffer’s vesicle also undergoes regional cell shape changes during
development. Interestingly, in the Kupffer’s vesicle the anterior cells are elongated
and the posterior cells shorten and widen over time (Wang et al., 2012), cell shape
changes that are similar to those described here for MHB morphogenesis.
Furthermore, these cell shape changes are regulated by non-muscle myosin II
activity (Wang et al., 2012); however, it was not determined if NMIIA and NMIIB
had distinct functions in the shortening or widening of cells. Future experiments to
determine the mechanisms that regulate cell shape changes such as length, width,
and basal constriction are essential for understanding complex morphogenetic
processes.
Function of NMIIA versus NMIIB
The DNA sequence and protein structural similarities between NMIIA and NMIIB
might suggest that these proteins are redundant; however, it is becoming more
apparent that each isoform has distinct functions. The function of these proteins
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has been determined using knockdown studies in many systems. NMIIA and
NMIIB knockout mice display different phenotypes, where NMIIA knockouts are
embryonic lethal due to cell adhesion defects (Conti et al., 2004), and NMIIB
knockouts present with heart, brain, and neuronal migration defects (Ma et al.,
2007; Ma et al., 2004). The ablation of NMIIB in mice resulted in structural
abnormalities in the brain of mice, consistent with the role for NMIIB neuroepithelial
morphogenesis (Tullio et al., 2001). Experiments to test for functional redundancy
between NMIIA and NMIIB have suggested only a limited ability for the proteins to
compensate for each other. For example, replacement of NMIIB with NMIIA in the
mouse rescues brain abnormalities, but does not rescue cardiac defects (Bao et
al., 2007). Here we have uncovered new isoform-distinct functions in regulating
cell shape at the MHB during brain morphogenesis.
NMIIA and NMIIB have different enzymatic properties during ATP-hydrolysis,
which determine their distinct roles in regulating cell shape. Only a small fraction
of the head domain of NMIIA is strongly bound to actin at any one time (Kovacs et
al., 2003). In contrast, NMIIB is one of the slowest myosins with regard to the rate
in which it translocates actin filaments by having a slow ATPase cycle; therefore it
spends a significantly longer time strongly bound to actin (Wang et al., 2003). This
longer binding may make NMIIB better suited for maintaining cellular tension.
These differences in enzymatic activity may account for the role of NMIIB in
regulating cell width and area throughout the MHB region, while NMIIA is working
more quickly to shorten cells in a specific brain region.
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Differential regulation of NMIIA and NMIIB
We determined that NMIIA and NMIIB proteins are not differentially distributed
within the cells at the MHB; however, we did discover that knockdown of one can
influence the localization of the other (Fig. 15). NMIIA and NMIIB are both activated
via phosphorylation of the myosin regulatory light chain (MRLC) (Bresnick, 1999;
Ito et al., 2004). Yet, NMIIA and NMIIB are differentially regulating cell shape in the
same cell resulting in distinct changes. From our previous work, we know that the
level of phosphorylated MRLC in the brain increases from 18 hpf to 21 hpf and
then goes back down by 24 hpf (Gutzman and Sive, 2010), indicating the NMII
activity is high in the brain during the time of morphogenesis investigated here.
MRLC activation can occur via multiple signaling pathways; including via myosin
light chain kinase (MLCK) and/or Rho-kinase (ROCK). In cell culture, MLCK and
ROCK specifically localize to regulate MRLC phosphorylation in a spatially
dependent manner. In 3T3 cells, ROCK is more active in phosphorylating MRLC
at the center of the cell, while MLCK is more active in phosphorylating MRLC at
the cell periphery (Totsukawa et al., 2004; Totsukawa et al., 2000). It was
demonstrated in migratory cells that a given cellular microenvironment may play a
role in determining the localization and function of specific NMII isoforms (Raab et
al., 2012). Although we do not see a difference in NMIIA and NMIIB localization in
normal tissue here, potentially the differential function of the two proteins is
determined by differential localization of their upstream activators which have yet
to be identified. Another possibility is that, although the proteins are localized in
the same parts of the cell, the orientation of the non-muscle myosin heavy chains
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may be oriented in opposing directions. For example, NMIIA fibers may run in an
apical to basal direction to regulate cell length, while NMIIB fibers may orient
perpendicularly to NMIIA to regulate cell width.
Non-muscle myosin heavy chains IIA and IIB can both be phosphorylated on
various sites to affect filament assembly and protein function (Vicente-Manzanares
et al., 2009). This raises the question as to whether or not there is a difference in
the phosphorylation state of the non-muscle myosin heavy chains themselves at
the MHB. Phosphorylation of the NMII heavy chains facilitates filament
disassembly and NMIIA and NMIIB have different sites in their tail domains making
this a possible level of differential activation and regulation. It was also recently
demonstrated that NMII isoforms can co-assemble in living cells, forming
heterotypic filaments that can perform both isoform specific and redundant
functions (Beach et al., 2014). It remains to be seen if these heterotypic filaments
are present in the neuroepithelium during development.
Differential distribution of actin with non-muscle myosin knockdown
It is established that NMII protein activity, in response to extra or intra-cellular
signals, contributes to the spatial organization of the actin network, resulting in
contractility and physiological functions (Kohler et al., 2011). Both NMIIA and
NMIIB knockdown resulted in abnormal actin distribution in the MHB region during
morphogenesis. Knockdown of NMIIA caused changes in actin localization within
the neuroepithelium and at the apical surface of the neural tube, while knockdown
of NMIIB caused abnormal actin distribution within the neuroepithelium, and at
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both the apical and basal surfaces of the neural tube. The location of actin affected
by NMII knockdown may provide some additional clues as to the regulation of the
NMII protein. Since mypt1 appears to regulate NMII activity apically, it is likely to
be regulating both NMIIA and NMIIB (Gutzman and Sive, 2010), which is
consistent with the mypt1 knockdown cell shape phenotypes as well. Actomyosin
activity is regulated on the basal surface of follicle cells by Rho, ROCK, and cellcell adhesion during Drosophila egg chamber development to cause contraction
(He et al., 2010). However, Drosophila have only one non-muscle myosin heavy
chain (zipper), indicating the importance for in vivo vertebrate studies to determine
how NMIIA and NMIIB are differentially regulating cell shape. These studies will
be essential to elucidate additional mechanisms of morphogenetic processes.
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Figure 9. myh9a, myh9b, and myh10 are expressed during the time of MHB
morphogenesis. (A) Diagram of the zebrafish myh9a, myh9b, and myh10 genes.
Domain regions are highlighted. Regions amplified for RT-PCR time course
expression are shown with arrows (primer details can be found in “Materials and
Methods”). Asterisks indicate the regions of the full length myh9a and myh9b in
the current Ensembl zebrafish genome that have not been completely annotated.
(B) RT-PCR analysis of myh9a, myh9b, and myh10 over a time course of
embryonic development spanning MHB morphogenesis. EF1α was used as a
control. Primer locations are indicated in panel A. (C) Time course of gene
expression by in situ hybridization for myh9a, myh9b, and myh10 in the developing
embryo from 4 hpf- 24 hpf. Each gene is shown with the antisense probe
expression pattern and sense control.
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Figure 10. Quantification of wild type tissue and cell shape changes during
MHB morphogenesis between 18 and 24 ss. (A-C) Live confocal imaging of wild
type embryos injected with mGFP and imaged at the stages indicated. (A’-C’)
Magnifications of images in A-C with individual cells outlined at the MHBC and
posterior to the MHBC towards the hindbrain. (D) Quantification of the MHB angle
on the basal side of the neuroepithelium (see dotted lines in A-C). (E)
Measurement of neural tube width as a representation of cell length in cells at the
MHBC over time. (F) Measurement of neural tube width as a representation of cell
length in cells 40 microns posterior to the MHBC over time. (G) Changes in the
percentage of cell shortening for cells at the MHBC compared to cells 40 microns
outside the MHBC over time. (H) Quantification of cell width measurements over
time. Arrowheads indicate MHBC. Asterisks in A-C indicate cells outlined in the
images below (A’-C’). One-way ANOVA with multiple t-test comparisons was
performed to determine significance, asterisks indicate p<0.001. Results are
shown as ± s.e.m. 18 ss; n = 9; 22 ss, n = 11, 24 ss, n = 11. Scale bars: 25 µm.
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Figure 11. myh9b, myh10 and mypt1 are required for MHB tissue
morphogenesis. (A-D) Brightfield dorsal view images of 24 ss embryos following
injection with (A) control MO, (B) myh9a MO, (C) myh9b MO, (D) myh10 MO.
Anterior is to the left in all images. Arrowheads indicate MHBC. Scale bars: 100
µm. (E-I) Live confocal images showing the MHB region of 24 ss zebrafish
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embryos injected with mGFP mRNA and coinjected with control MO (E), myh9a
MO (F), myh9b MO (G), myh10 MO (H), or mypt1 MO (I). (J) Quantification of the
MHB angle on the basal side of the neuroepithelium (see angle lines in E-I). Oneway ANOVA with multiple t-test comparisons was performed to determine
significance between control and test groups. Asterisks indicate p<0.001. Results
are shown as ± s.e.m. For E-I; control MO, n = 48; myh9a MO, n = 10; myh9b MO,
n = 16; myh10 MO, n = 18; mypt1 MO, n = 20.
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Figure 12. myh9b is required for cell shortening at the MHBC during
morphogenesis. (A-F) Live confocal images showing the MHB region of 24 ss
zebrafish embryos injected with mGFP and coinjected with control MO (A-B),
myh9a MO (C), myh9b MO (D), myh10 MO (E), or mypt1 MO (F). (G)
Quantification of the cell length (X) at the MHBC (see lines in A, C-F). (H)
Quantification of cell length 40 microns outside of the MHBC (Y) (see lines in B-F).
One-way ANOVA with multiple t-test comparisons was performed to determine
significance between control and test groups. Asterisks indicate p<0.001. Double
asterisks indicate p<0.05. Results are shown as ± s.e.m. Control MO, n = 48;
myh9a MO, n = 10; myh9b MO, n = 16; myh10 MO, n=18; mypt1 MO, n=20. Scale
bars: 25 µm.
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Figure 13. myh10 is required for regulation of cell width in the MHB during
morphogenesis. (A-E) Live confocal images showing one side of the MHB region
of 24 ss zebrafish embryos injected with mGFP and coinjected with control MO
(A), myh9a MO (B), myh9b MO (C), myh10 MO (D), or mypt1 MO (E). Single
representative cells are outlined in each panel. (F) Quantification of the cell width.
(G) Quantification of cell area. One-way ANOVA with multiple t-test comparisons
was performed to determine significance between control and test groups.
Asterisks indicate p<0.001. Double asterisks indicate p<0.05. Results are shown
as ± s.e.m. For each embryo (n) a total of 6 cells were outlined: 2 cells at the MHBC
were outlined, 2 cells 40 microns posterior to the MHBC were outlined, and 2 cells
within the 40 micron region between the MHBC and posterior were outlined. Cells
were chosen based on the ability to see an entire cell from apical to basal in a
single z-section. Control MO, n = 9; myh9a MO, n = 9; myh9b MO, n = 14; myh10
MO, n=9; mypt1 MO, n=9. Scale bars: 25 µm.
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Figure 14. Actin distribution is dependent upon non-muscle myosin II
function. (A-F) Embryos were injected as indicated and stained with phalloidin
(green) to determine actin localization and regional enrichment. (A-C) Control
morphant embryos with normal actin distribution at the MHB. Boxes indicate areas
of comparison for determining the mean actin intensity ratio. (A) Comparison of
actin intensity with the neuroepithelium at the MHBC region (box 1) compared to
the posterior MHB (box 2). (B) Comparison of actin intensity apically at the midline
(box 1) compared to the apical region within the neuroepithelial tissue (box 2). (C)
Comparison of actin intensity on the basal side of the neuroepithelium (box 1)
compared to the basal region within the neuroepithelial tissue (box 2). (G)
Quantification of actin distribution comparison ratios for control MO, myh9b MO,
myh10 MO, and mypt1 MO injected embryos in the regions indicated. One-way
ANOVA with multiple t-test comparisons was performed to determine significance
between control and test groups. Results are shown as ± s.e.m. Asterisks indicate
significance compared to control, p<0.001. Double asterisks indicate, p<0.01.
Arrowheads indicate MHBC. Control MO, n = 8; myh9b MO, n = 12; myh10 MO,
n=13; mypt1 MO, n=8.
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Figure 15. Non-muscle myosin IIA and IIB protein localization. (A-C) NMIIA
and NMIIB antibody staining in 24 ss embryos injected with control MO. (A) NMIIA
antibody (green), (B) NMIIB antibody (red), (C) overlay of A and B. (D) Overlay of
NMIIA and NMIIB immunostaining in a 24 ss mypt1 MO injected embryo. (E) NMIIA
staining with myh10 MO knockdown. (F) NMIIB staining with myh9b MO
knockdown. (G-H) No primary control from Alexa 488 and Alexa 555 secondary
antibodies. Results are representative of at least three independent experiments.
Control MO, n = 8; mypt1 MO, n = 7; myh10 MO, n = 14; myh9b MO, n = 19; Alexa
488 no primary control, n = 5; Alexa 555 no primary control, n = 5.
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Figure 16. Model for non-muscle myosin IIA and IIB differential regulation of
cell shape changes at the MHB during brain morphogenesis. (A)
Representation of a wild-type or control morphant embryo at 24 ss with
magnification of the MHB region and simplified model of cell shape at the MHB.
Wild-type and control morphants have an MHB angle of approximately 100
degrees and cells at the MHBC are almost 25% shorter than surrounding cells,
while all cells have equal cell width. (B) myh9b knockdown results in an increase
in the MHB angle to 125 degrees and this angle difference is due to cells
specifically at the MHBC not shortening normally. (C) myh10 loss-of-function
results in an increase in the MHB angle to 140 degrees as a result of increase in
cell width with normal cell length at the MHBC. (D) mypt1 knockdown, and
increased activation of both NMIIA and NMIIB, results in both shorter and wider
cells throughout the region leading to an increase in the MHB angle to 130
degrees.
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Supplemental Materials

Figure S 1. Details for morpholino induced splice variation and sequence
analysis. Single cell embryos were injected with 4ng control MO + 4ng p53 MO,
4ng myh9a MO, 3ng myh9b MO + 3ng p53 MO, or 3ng myh10 MO. All MO
confirmation experiments were conducted using the same concentration of MO as
was used for all imaging and analysis experiments described in the “Materials and
Methods”. RNA was collected from control and experimental morphant injected
embryos at 24 hpf for RT-PCR analysis. For each MO used, aberrant splicing was
detected, as well as a decrease in wild-type transcript. EF1α was used as a control
for each RT-PCR experiment. (A) Analysis from RT-PCR experiments confirmed
that injection of 4ng of myh9a MO resulted in an inclusion of intron 1-2. Wild-type
transcript was detected in both control and myh9a morphants using the following
primers, myh9a forward primer 1 (within Exon1) (5’-AAATTCAGCAAGGTG
GAGGA-3’); myh9a reverse primer 1 (within Exon4) (5’-TTGGTGTTTTCGGTTT
TTCC-3’). Aberrant splicing and the inclusion of intron 1 was detected only in the
myh9a morpholino injected embryos using the following primers; myh9a forward
primer 2 (within intron 1-2) (5’-tgcaaacttgagctttgtgtt-3’) and myh9a reverse primer
2 (within Exon 8) (5’-GCACGGGACTTCTCCAATAG-3’). Diagram depicts location
of primers, morpholino target, and abnormal splicing product with MO injection. (B)
RT-PCR analysis confirmed that injection of 3ng of myh9b MO disrupts normal
RNA processing. The myh9b MO caused three abnormal splice changes; a
deletion of Exon 6, and two different length inclusions of intron 6-7. In addition,
while investigating the effect of the myh9b morpholino on mRNA splicing, upon
sequencing RT-PCR products following MO injection, we discovered an
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unannotated putative exon between the current Ensembl annotation of Exon 5 and
Exon 6 which we have termed Exon 5a. Initial experiments to test for aberrant
splicing were conducted using the following primers: myh9b forward primer 1
(within Exon 3) (5’-GGTGAATCTGGAGCTGGAAA-3’), and myh9b reverse primer
1 (within Exon 8) (5’-TGTGGAAGGTTCGCTCTTCT-3’). Using these primers we
discovered that our control samples consistently amplified two bands that were
very close in size. Upon sequencing of both control bands, and myh9b MO RNA
samples, we determined that we had discovered an additional unannotated exon
that we have termed Exon 5a. For further testing of the morpholino activity we
designed a primer to the Exon5a sequence which allowed us to clearly define the
splice changes induced by the myh9b MO without multiple bands for each aberrant
splicing product. The short Exon 5a sequence (previously annotated as intron) is
as follows: “AGCAGCTCCGTCCTGTCA CATGGT”. Primers used for the analysis
presented in panel B include: myh9b forward primer 2 (within Exon5a) (5’GCAGCTCCGTCCTGTCAC-3’); myh9b reverse primer 1 (within Exon 8) (5’TGTGGAAGGTTCGCTCTTCT-3’). Diagram depicts location of primers,
morpholino target, Exon 5a, and abnormal splicing products found with MO
injection. (C) RT-PCR analysis confirmed that injection of 3ng of the myh10 MO
causes a deletion of exon2. myh10 forward primer: (within Exon 1) (5’-CTTC
TGAACGGCATGGATTT-3’), myh10 reverse primer: (within Exon7) (5’-TTGGCAT
TTCCAAAGGATTC- 3’). Diagram depicts location of primers, morpholino target,
and abnormal splicing product with MO injection. Each abnormal splice variant
from these morpholino injections resulted in a frame shift and the introduction of
an early stop codon. (D) Representative Western blot for analysis of myh10 MO
knockdown. Wild-type embryos were injected with control or myh10 MO as
described above. At 24 ss the yolk was manually removed from the whole embryo
and the whole tissue protein was isolated with a protease inhibitor cocktail (Roche,
04693124001) as previously described (Gutzman and Sive, 2010). Antibodies
include, anti-myosin IIB antibody (Santa Cruz Biotechnology, sc-376942, 1:500),
anti-α-tubulin (Sigma-Aldrich, T6199, 1:2000), anti-mouse IgG HRP-linked
antibody (Cell Signaling Technology Inc., #7076, 1:2000). Blots were imaged using
Foto/Analyst Luminary FX imager with Foto/Analyst PC Image software (Fotodyne
Inc.). Protein levels were quantified and compared with the α-tubulin controls using
Photoshop from four independent experiments.
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Figure S 2. Whole embryo phenotypes for morpholino injected embryos.
Single cell embryos were injected with (A,B) 4ng control MO + 4ng p53 MO, (C,D)
4ng myh9a MO, (E,F) 3ng myh9b MO + 3ng p53 MO, or (G,H) 3ng myh10 MO.
Live embryos were imaged using brightfield microscopy at 24 ss and at 48 hpf as
indicated. myh9a morphants did not demonstrate any obvious phenotypes at the
times imaged. For myh9b and myh10 morphants, representative mild phenotypes
are shown. myh9b morphants demonstrated somite defects, abnormal tail
curvature, pigmentation defects, heart abnormalities, slight edema, and abnormal
eye and ear formation. myh10 morphants had abnormal body axis curvature, heart
abnormalities, slight edema, and abnormal eye development.
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Figure S 3. Rescue of the myh9b and myh10 knockdown MHB phenotype
with human mRNA injection. Embryos were injected at the one cell stage with
human MYH9 or MYH10 mRNA in conjunction with morpholino injections. The
human full length DNA for MYH9 was obtained from Addgene clone 10844 and
subcloned into the pCS2+ vector for mRNA expression. Human full length DNA for
MYH10 was obtained from Addgene clone 10845 and subcloned into the pCS2+
vector for mRNA expression. mRNA was transcribed using the mMessage
mMachine kit (Ambion). Graphs depict the distribution of “normal”, “mild”, and
“severe” MHB phenotypes at 24 ss for each treatment group shown. (A) Embryos
injected with myh9b MO combined with human MYH9 mRNA showed partial
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rescue of the MHB phenotype. Control MO + mGFP, n=140; myh9b MO + mGFP,
n= 148; myh9b MO + MYH9 mRNA, n=157. (B-D) Representative images
demonstrating the “normal”, “mild”, and “severe” myh9b MO phenotypes scored.
(E) Rescue of myh10 MO injected embryos with human MYH10 mRNA. Embryos
injected with myh10 MO combined with human MYH10 mRNA showed partial
rescue of the MHB phenotype. Control MO + mGFP, n= 90; myh10 MO + mGFP,
n= 106; myh10 MO + MYH10 mRNA, n=120. (F-H) Representative images
demonstrating the “normal”, “mild”, and “severe” myh10 MO phenotypes scored.
For myh9b MO rescue 100 pg of MYH9 mRNA was co-injected, and for myh10
MO rescue 200 pg of MYH10 mRNA was co-injected. Chi-squared test with a 3X3
contingency table (df=4) was performed to test for statistical significance between
the three treatment groups and the number of embryos with normal, mild, or severe
phenotypes. For panel A (myh9b rescue data) Chi-squared = 206.79, p<0.00001.
For panel E (myh10 rescue data) Chi-squared = 144.04, p<0.00001.
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Figure S 4. myh9b and myh10 knockdown does not affect cell proliferation
or cell death at the MHB. (A-C) Representative confocal images of control (A),
myh9b MO (B), and myh10 MO (C) injected embryos that were fixed at 24 ss and
stained with PH3 (green) to label proliferating cells. Embryos were fixed in 4%
PFA, deyolked, rinsed in PBT and blocked overnight in (2% NGS, 2% BSA, 1%
DMSO, 0.5% TritonX in PBS). Embryos were incubated in primary anti-PH3
antibody, (Millipore, 1:800) overnight, washed, and incubated in secondary
antibody Alexa Fluor 488 (goat anti rabbit, 1:500). Propidium iodide was used to
stain for nuclei (Invitrogen, P3566, 1:1000 in PBT) for 1 hour. Embryos were
washed, mounted in glycerol and imaged using Nikon CS2 laser scanning confocal
microscope. Boxes indicate the region of the brain where total cell number and
PH3 positive cells were counted within the neural tissue. (D) Quantification of the
percentage of PH3 positive cells within the region. Control MO, n=22; myh9b MO,
n=14; myh10 MO, n=10. Results are shown as mean ± s.d. No significant
differences were detected. (E-G) Representative confocal images of control (E),
myh9b MO (F), and myh10 MO (G), injected embryos that were fixed at 24 ss and
TUNEL labeled (green) to indicate apoptotic cells. All embryos were counter
stained with propidium iodide (red) to label all cells. Apoptosis was detected by
the TUNEL method using the Apoptag Kit (Millipore) according to the provided
protocol using fluorescent detection of apoptotic cells. Embryos were
counterstained with propidium iodide to label nuclei and imaged by laser-scanning
confocal microscopy (Nikon CS2). Boxes indicate the region of the brain where
total cell number and TUNEL positive cells were counted within the neural tissue.
(H) Quantification of the percentage of TUNEL positive cells within the region.
Control MO, n=10; myh9b MO, n=14; myh10 MO, n=10. Results are shown as
mean ± s.d. No significant differences were detected.
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CHAPTER 3
CALCIUM REGULATES CELL LENGTH DURING
ZEBRAFISH MIDBRAIN-HINDBRAIN BOUNDARY
DEVELOPMENT
A. INTRODUCTION
Calcium signaling plays a vital role in various developmental processes including
gastrulation and establishment of body axis (Gilland et al., 1999; McGrath et al.,
2003). It promotes airway branching morphogenesis in the developing lung
(Brennan et al., 2013) and is important in neuronal development in axonal and
dendritic morphogenesis (Ramakers et al., 2001). Calcium is also involved in
cellular morphogenesis. Influx of extracellular calcium is required for epithelial cell
contraction in carcinoma cell lines (Lee and Auersperg, 1980) and it plays an
important role in cell shape change in platelets and endothelial cells (Moore et al.,
1998; Porter et al., 2003). Thus, calcium is involved in many developmental and
cellular morphogenetic events.
In order for calcium signaling to promote morphogenesis, it must act on
downstream effectors of cell shape such as cytoskeletal elements. Gastrulation,
dorsal closure and egg chamber elongation are some developmental events that
are separately known to be regulated by calcium and non-muscle myosin II (NMII)
(Franke et al., 2005; Hunter et al., 2014; Tada and Concha, 2001). Calcium
signaling has been classically studied to regulate NMII activity in skeletal and
smooth muscle contraction (Porter et al., 2003; Somlyo and Somlyo, 2003; Szent-
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Gyorgyi, 1975). Some studies have indicated this interaction to be mediated by
myosin light chain kinase (Martinsen et al., 2013; Watanabe et al., 2001).
Using the zebrafish midbrain-hindbrain boundary (MHB) as a model to study
epithelial brain morphogenesis, we previously characterized the cell shape
changes that occur during MHB formation. We found that the cell shape changes
are regulated by non-muscle myosin II (NMII) proteins (Gutzman et al., 2015 and
chapter 2) and NMII activity depends on the phosphorylation state of the myosin
light chain (MLC) (Gutzman et al.,2010). The myosin phosphatase holoenzyme
dephosphorylates the MLC, and is regulated by the Mypt1 inhibitory regulatory
subunit. We have shown that mypt1 morphants have an abnormal MHB, due to an
overactivation of NMII and a cell shape phenotype of shorter and wider cells in the
MHB region (Gutzman et al., 2015 and chapter 2). The molecules directly affecting
the phosphorylation state of NMII are in turn regulated by upstream signaling
pathways which are yet to be elucidated.
In the current study, we hypothesized that the calcium signaling pathway regulates
NMII during zebrafish MHB formation. We found that calcium is required for proper
MHB development in zebrafish and depletion of intracellular calcium release from
the endoplasmic reticulum (ER) by treatment with the pharmacological inhibitor, 2aminoethoxy phenyl borate (2-APB) showed that the cells at the MHB constriction
(MHBC) do not shorten normally. We further discovered that the cell length
phenotype seen in mypt1 morphants can be rescued by inhibition of intracellular
calcium release. Overactivation of NMII by mypt1 knockdown leads to shorter
MHBC cells while inhibition of calcium release results in longer MHBC cells.
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Successful rescue of the mypt1 phenotype by calcium inhibition suggests that both
molecules may be part of the same signaling pathway regulating the formation of
the zebrafish MHB. Thus, teasing apart this pathway can help in improving our
understanding

of

similar

mechanisms

involved

in

other

developmental

morphogenetic events.
B. MATERIALS AND METHODS
Animals
Wild-type AB zebrafish were raised and staged according to standard protocols as
previously described (Kimmel et al., 1995). Embryos were staged according to
somite stage (ss) for accuracy. 18 ss is 18 hpf and 24 ss is 22 hpf.
Microinjections
Splice-site blocking morpholino antisense oligonucleotides were injected at onecell stage with a co-injection of membrane GFP (mGFP) at a concentration of 200
ng/µl. mGFP allows visualization of individual cell outlines during confocal imaging.
Mypt1 MO (5-ATTTTTTGTGACTTACTCAGCGATG-3; Gene Tools) that targets
exon 2-intron 2 of the zebrafish mypt1 was used at a concentration of 5 ng/µl
(Gutzman and Sive, 2010). A standard control MO (5-CCTCTTACCTCAG
TTACAATTTATA-3) and p53 morpholino (5-GCGCCATTGCTTTGCAAGAATTG3) were also used at equivalent concentrations of 5 ng/µl (Gene Tools).
Drug treatments
Embryos were treated with 2-aminoethoxy phenyl borate (2-APB, Sigma D97541G) at 18 ss for 10 minutes at a concentration of 100 µM from a stock solution of
100 mM, and washed in 1X Danieau’s solution.
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Calcium imaging
Calcium green-1 dextran (Invitrogen molecular probes C3714) and dextran
tetramethyl rhodamine (Invitrogen molecular probes D1818, 70000 MW) were
injected into embryos at one-cell stage. At 4 hpf, they were manually
dechorionated and placed on a glass slide in 0.1% DMSO prepared in 1X
Danieau’s solution for 10 minutes. Time lapse confocal images were taken once
every 10 seconds for 10 minutes to detect calcium signals. The same embryo was
imaged again by replacing the solution with 100 µM 2-APB prepared in 1X
Danieau’s solution after a 10 minute treatment. Changes in fluorescence intensity
in individual cell regions were quantified using the NIS Elements analysis software
(Nikon).
Western blotting
Wild-type AB embryos were treated with the pharmacological inhibitor 2-APB at
100 µM for 10 minutes at 18 ss. Following morpholino and drug treatment, while in
the drug, embryos were dissected posterior to the ear to collect the head portion
in a buffer containing Tris (pH 8.0), 10% glycerol, 1% Triton X-100 and protease
inhibitor cocktail (Roche- 04693124001). Using a syringe, protein was extracted in
lysis buffer and the concentration was estimated using the Bradford assay. 40 µg
protein was analyzed by Western blotting. Primary antibody pMLC (Cell signaling
#3671) was used at a concentration of 1:1000 and control primary antibody
HDAC1 (Abcam ab41407) was used at 1:500. Secondary antibodies, anti-mouse
HRP (Cell signaling technologies #7076S) and anti-rabbit HRP (Cell signaling
technologies #7074S), were used at a dilution of 1:2000. PVDF membranes were
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developed using the Supersignal West Femto maximum sensitivity substrate
(Thermoscientific #34095) or the clarity Western ECL substrate (Bio-rad
technologies #170-5060). Blots were imaged using a Foto/Analyst FX Imager with
Foto/Analyst PC Image software (Fotodyne Inc.) or a Biospectrum 810 imager
system (UVP, LLC), and quantified on Photoshop.
Imaging and analysis
Brightfield images were taken using an Olympus SZX12 stereomicroscope with an
Olympus DP72 camera. Live embryo confocal imaging was carried out as
previously described using Nikon CS2 laser scanning confocal camera and Nikon
Elements software (Gutzman et al., 2015 and Chapter 2). Cell shapes were
measured and analyzed using Nikon Elements Software, as previously described
(Gutzman et al., 2015 and Chapter 2).
Statistical analysis
Statistical analysis was carried out using the Mann-Whitney U-test. This test was
used to determine significance between two groups of data (control and treatment
group) having unequal sample sizes (n). p-values denoting significance are
reported for each experiment within the figure legend.

C. RESULTS
Calcium regulates cell length at the MHBC
To investigate the potential role of calcium signaling in zebrafish MHB
development, we utilized the pharmacological drug, 2-aminoethoxy diphenyl-
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borate (2-APB), that inhibits the IP3 receptor (IP3R) present on the endoplasmic
reticulum (ER), preventing it from opening the calcium channel and consequently
inhibiting the release of calcium into the cytosol (Ma et al., 2001; Taylor and Tovey,
2010). We treated zebrafish embryos at 18 ss, immediately before MHB formation
begins, with 2-APB or DMSO (Fig. 17A). The embryos were then allowed to
develop to 24 ss and imaged using confocal microscopy in order to obtain single
cell resolution images. We found that 2-APB treated embryos had abnormal MHB
when compared to DMSO treated embryos (Fig. 17B-C’). We further quantified
tissue and cell shape changes during MHB formation in the treatment groups (Fig.
17D-E). Measurement of MHBC tissue angle showed a greater, more obtuse angle
in 2-APB treated embryos (Fig. 17D and Fig. 18). This phenotype corresponds to
an abnormal MHB phenotype, indicating insufficient tissue folding. Interestingly,
the width of the neural tube at the MHBC, which represents the MHBC cell length,
was also found to be greater in 2-APB treated embryos when compared to DMSO
treated embryos (Fig. 17E and Fig. 18). Additional measurements including the
width of the neural tube 40 µm away from the MHBC towards the hindbrain, the
cell width, and the cell area, all remained unchanged in the 2-APB treated embryos
(Fig. 18). Longer MHBC cells upon calcium inhibition suggest a role for calcium
signaling in regulating cell length at the MHBC.
In order to confirm the efficacy of 2-APB in decreasing cytosolic calcium levels, we
used live imaging of calcium green, a calcium indicator dye that fluoresces green
when bound to calcium molecules, enabling us to visualize calcium ‘spikes’ during
development, as previously published by Fetcho, 2007; Reinhard et al., 1995. We
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injected single-cell stage embryos with calcium green-1 dextran and treated
embryos with DMSO or 2-APB to visualize calcium spikes using confocal
microscopy (Fig. 19). We carried out this experiment at an early time point of 4 hpf
since the fluorescent signals were undetectable at 24 ss (data not shown). A timelapse of confocal images for each embryo was taken to quantify the changes in
fluorescence intensity. We found that approximately 2-3 cells in the enveloping
layer of DMSO treated embryos distinctly fluoresced within this time frame in the
region being imaged (Fig. 19A). Next, we treated the same embryo with 2-APB
and again carried out time-lapse confocal imaging. We were unable to observe
any obvious change in fluorescence in the embryo (Fig. 19B). To quantify these
data, we took a ratio of the highest to lowest fluorescence intensity in a given cell
area during the period of visualized calcium spikes. Comparison of this fold change
in intensity showed that DMSO treated embryos had an average fold change of
1.364 compared to a significantly reduced fold change of 1.2 in 2-APB treated
embryos (Fig. 19C). We concluded that at 4 hpf, 2-APB decreases the amounts of
cytosolic calcium in zebrafish embryos and is an important confirmation of the
efficacy of 2-APB as previously published (Fetcho, 2007; Reinhard et al., 1995).
Together, these data indicate that calcium is required for proper MHB formation in
the zebrafish by regulation of MHBC cell length.

Overactivation of NMII is rescued by decreasing cytosolic calcium
It is known from previous studies that calcium signaling is involved in regulation of
cell length in various cell culture models (Bramlage et al., 2001; White et al., 1993).
It is also involved in regulation of NMII activity (Somlyo and Somlyo, 2003; Szent-

93

Gyorgyi, 1975). Therefore, we hypothesized that calcium signals to NMII to
regulate cell length during zebrafish MHB formation. In order to test this
hypothesis, we utilized mypt1 morphant embryos and ER calcium inhibition. Mypt1
knockdown results in overactivation of NMII and leads to abnormal cell shapes at
the MHB with shorter and wider cells (Fig. 20A and Gutzman et al., 2015). We
have also shown that reduction of cytosolic calcium by 2-APB results in abnormal
MHB with longer MHBC cells (Fig. 17 and Fig. 20B). Therefore, we hypothesized
that if calcium signals to NMII, then the cell shape phenotype of overactivation of
NMII could be rescued by decreasing cytosolic calcium (Fig. 20C). We injected
mypt1 morpholino into single cell stage embryos along with mGFP and treated
them with 2-APB at 18 ss, followed by confocal imaging and cell shape analysis at
24 ss (Fig. 20D-E). We found no difference in the MHB tissue angle in DMSO and
2-APB treated mypt1 morphants (Fig. 20F and Fig. 21). In fact, the angle
phenotype observed with both treatments was the same as what we found in
mypt1 morphants previously (Chapter 2, Figs. 11-13) However, the length of the
cells at the MHBC in 2-APB treated mypt1 morphants was significantly longer
compared to DMSO treated mypt1 morphants (Fig. 20G and Fig. 21). This was the
only parameter that was significantly different in our quantification of
morphogenetic changes in tissue and cell shape. We did not find any difference in
cell length 40 µm away from the MHB towards the hindbrain, cell width, and cell
area (Fig. 20F-G and Fig. 21). These data indicate a rescue of the MHBC cell
length phenotype, from shorter MHBC cells seen in the mypt1 morphants to
comparatively longer MHBC cells upon calcium inhibition. Although the cell length
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was rescued, the MHB angle was still abnormally large because the cell width was
not rescued. We know from our previous work that either cell length or cell width
abnormalities can result in abnormal tissue angle, which explains why a rescue of
only cell length does not rescue the MHB tissue angle (Chapter 2, Figs. 11-13).
Thus, in mypt1 morphants, MHBC cell length is the sole cell shape parameter
measured that is rescued by inhibition of cytosolic calcium.
To further test for calcium as an upstream signal regulating NMII, we hypothesized
that inhibition of calcium ER release by 2-APB would result in reduced amounts of
phosphorylated MLC (pMLC), which would be an indication of activation of NMII
molecules. However, Western blotting determined no significant changes in pMLC
levels (Fig. 22A). We have previously seen that knockdown of mypt1 in zebrafish
brain leads to increased quantities of pMLC (Gutzman and Sive, 2010). In order to
take a different approach, we hypothesized that mypt1 morphants with increased
pMLC levels would show a visible reduction in the pMLC amount when treated with
2-APB. Surprisingly, we did not find any changes in pMLC levels here as well (Fig.
22B). This could be attributed to the small size of the pMLC protein, making the
change undetectable on blots. Therefore, the role for calcium signaling in
regulation of pMLC requires further investigation. From these experiments, we
conclude that calcium signaling is required for proper shortening of MHBC cells
during this morphogenetic process.
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D. DISCUSSION
Calcium regulates cell length during MHB formation
Calcium ions can enter the cell from the external environment through calcium
channels on the cell membrane, or from intracellular storage organelles, and affect
cytosolic calcium concentration (Westfall et al., 2003). One major source of
intracellular calcium is the ER, where opening of calcium channels are regulated
by IP3R (Berridge et al., 2003; Berridge et al., 2000; Slusarski and Pelegri, 2007).
Calcium signaling has been previously studied for its role in regulating cell shape
in platelet and endothelial cells (Moore et al., 1998; Porter et al., 2003). Here, our
investigation of the role of calcium signaling in zebrafish MHB formation identified
an important role for calcium in cellular morphogenesis. We found that calcium is
required for proper MHB formation and has a specific role in cell shortening at the
MHBC (Fig. 17). Regulation of cell shortening by calcium waves has been
previously seen in adult cardiac myocytes in vitro (Bramlage et al., 2001). For the
first time, we show calcium mediated regulation of cell length during
morphogenesis in a live vertebrate model. Additionally, this result draws a potential
important correlation to our previous finding of the role of NMIIA in regulating cell
length during zebrafish MHB formation (Gutzman et al., 2015). Both inhibition of
ER calcium release and NMIIA knockdown show the same MHB cell shape
phenotype, possibly suggesting that both molecules may be functioning as part of
the same signaling pathway (Fig. 23B).
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Calcium regulates cell length during MHB formation through NMII
Although there have been studies involving calcium mediated regulation of NMII
activity, these studies have been mostly done in cell culture (Martinsen et al., 2013;
Watanabe et al., 2001). Here, we show that the cell length phenotype in mypt1
morphants, with overactive NMII, is rescued when calcium release from the ER is
inhibited, suggesting an important correlation between the two signaling
molecules. Interestingly, we observed that the MHB tissue angle is not rescued
along with the cell length phenotype. A possible explanation could be that the cell
width phenotype of mypt1 morphants is not rescued and we know that cell width
is also a contributor to normal MHB tissue angle (Chapter 2, Gutzman et al., 2015).
Myosin phosphatase dephosphorylates the MLC for both NMII homologs, NMIIA
and NMIIB. Hence, knockdown of mypt1 inhibits the action of myosin phosphatase
for both class II non-muscle myosins, resulting in overactive NMIIA and NMIIB
(Hartshorne et al., 2004). Rescue of only the cell length phenotype of mypt1
knockdown by calcium inhibition, leads us to hypothesize that calcium specifically
regulates NMIIA. Thus, we hypothesize that both calcium and NMIIA function in
the same signaling pathway through intermediate signaling molecules (Fig. 23B).
Calcium, being an inorganic molecule, typically interacts with calcium binding
proteins to signal to downstream molecules such as ones that make up the
cytoskeleton. Calmodulin is a calcium binding protein and has been shown to be
required for morphogenesis in yeast (Kraus et al., 2005; Paranjape et al., 1990).
Calcium, calmodulin and myosin have also been studied together to regulate cell
shape change in Euglena (Lonergan, 1984; Lonergan, 1985). Additionally, it has
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been shown that various CAM kinase II isoforms are expressed in the zebrafish
brain during early development, making calmodulin a possible candidate in
zebrafish MHB development (Rothschild et al., 2007). The activation of NMII is
carried out by various kinases such as the myosin light chain kinase (MLCK), also
a potential molecule in the calcium signaling pathway due to its involvement in
various developmental morphogenetic processes (Ewald et al., 2008). A proposed
model for the regulation of NMII activity through the calcium signaling pathway is
shown in figure 23B. The precise molecular interactions between these molecules
are yet to be determined and serve to be the basis of future experiments.
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Figure 17. Calcium regulates cell length during MHB formation. (A)
Experimental procedure. Single cell stage zebrafish embryos were injected with
mGFP, treated with 0.1% DMSO or 100 µM 2-APB at 18 ss, and imaged at 24 ss.
(B-C) Confocal images of treated embryos as indicated at 24 ss. (B’-C’)
Magnifications of images in B-C showing shape outlines of cells marked with
yellow asterisks. Arrowheads indicate MHBC. (D) Comparison of average tissue
angle at the MHBC and (E) average width of the neural tube at the MHBC (see
lines in B,C). Mann-Whitney U-test was performed to determine significance
between control and test groups. Asterisk indicates p< 0.05. DMSO, n=9; 2-APB,
n=8. Error bars are ±s.e.m.
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Figure 18. Quantification of cell shape parameters in 2-APB treated embryos.
(A) Neuroepithelial MHB tissue angle, (B) Width of the neural tube at the MHBC or
cell length at th MHBC, (C) Width of the neural tube 40 µm away from the MHBC
or cell length 40 µm away from the MHBC towards the hindbrain region, (D) Cell
width and (E) Cell area. Mann-Whitney U-test was performed to determine
significance between control and test groups. Asterisk represents p< 0.05. For
angle and cell length measurements, n=12; for cell width and area measurements,
n=7. Error bars are ±s.e.m.
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Figure 19. Calcium green-1 dextran imaging confirms inhibition of
intracellular calcium levels by 2-APB. (A-B) Timelapse confocal images of
zebrafish embryos injected with the calcium indicator and treated and imaged at 4
hpf with (A) 0.1% DMSO and (B) 100 µM 2-APB. Timelapse was done once every
10 seconds for 10 minutes. Arrows and arrowheads indicate rapidly changing
calcium dynamics in two different cells. (C) Quantification of change in
fluorescence intensity. Mann-Whitney U-test was performed to determine
significance between control and test groups. Asterisk indicates p<0.001. n=6
each. Error bars are ±s.e.m.
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Figure 20. Inhibition of cytosolic calcium rescues cell length phenotype of
overactivation of NMII. (A-C) Schematic of experimental hypothesis. (A) Mypt1
knockdown results in overactivation of myosin light chain and abnormal MHB with
shorter and wider MHB cells. (B) Inhibition of calcium release from ER by 2-APB
results in abnormal MHB with longer MHBC cells. (C) IF: calcium signals to NMII,
THEN: inhibition of calcium release in mypt1 knockdown embryo would rescue
MHB cell shape phenotype. (D-E) Confocal images of 24 ss embryos injected with
mGFP and mypt1 morpholino and treated with (D) 0.1% DMSO and (E) 100 µM 2APB at 18 ss. (D’-E’) Magnified images from D-E. Arrowheads indicate MHBC. (FI) Quantification of cell shape changes occuring during MHB formation- (F) MHBC
tissue angle, (G) width of the neural tube at the MHBC, (H) width of the neural tube
40 µm away from the MHBC and (I) cell width. Only width of the neural tube at the
MHBC (G) is different between the two treatment groups. Mann-Whitney U-test
was performed to determine significance between control and test groups. Asterisk
indicates p<0.01. For angle and length measurements, DMSO, n=13; 2-APB,
n=17; for cell width measurement, n=13 embryos each. Error bars are ±s.e.m.
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Figure 21. Quantification of cell shape parameters in 2-APB treated mypt1
morphant embryos. Quantification of cell shape parameters in 2-APB treated
mypt1 morphant embryos. (A) Neuroepithelial MHB tissue angle, (B) Width of the
neural tube at the MHBC or cell length at the MHBC, (C) Width of the neural tube
40 µm away from the MHBC or cell length 40 µm away from the MHBC towards
the hindbrain region, (D) Cell width and (E) Cell area. Mann-Whitney U-test was
performed to determine significance between control and test groups. Asterisk
indicates p<0.01. For angle and length measurements, DMSO, n=13; 2-APB,
n=17. For cell width and area measurement, n=13 embryos each. Error bars are
±s.e.m.
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Figure 22. pMLC Western blotting. (A) Western blotting for pMLC using wildtype embryonic brain tissue treated with DMSO or 2-APB showed no difference
in phosphorylation of MLC. Graph represents quantification of Western blotting
data and is an average of six independent experiments. Mann-Whitney U-test
was performed to determine significance between control and test groups. Error
bar is ±s.e.m. (B) Western blotting for pMLC using mypt1 morphants treated with
DMSO or 2-APB also showed no difference in phosphorylation levels of NMII.
Hdac1 was used as loading control.
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Figure 23. Summary and hypothesized model of the calcium signaling
pathway regulating NMII. (A) Diagram representing a zebrafish embryonic brain
viewed dorsally with magnified view of the MHB and a simplified model depicting
normal MHB cell shapes at 24 ss. Control or wild-type embryos have a normal
MHB tissue angle of 100 degrees while decrease in cytosolic calcium leads to
abnormal MHB formation due to MHBC cells not shortening properly. Figure
adapted from Gutzman et al., 2015. (B) Diagram representing the hypothesis that
the calcium signaling pathway via calmodulin and myosin light chain kinase,
signals to activate NMIIA, regulating cell length during zebrafish MHB
morphogenesis. Red arrows indicate hypothesized interaction.
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CHAPTER 4
CONCLUSIONS AND FUTURE DIRECTIONS
A. CONCLUSIONS
The primary aim of this project was to characterize the morphogenetic events
occurring during midbrain-hindbrain boundary (MHB) formation using zebrafish as
a model, and further understand and elucidate the mechanisms responsible for
this epithelial morphogenetic process. We first characterized the neuroepithelial
cell shape changes that occur during this process (Chapter 2, Fig. 10). We
concentrated on a shorter time frame when the MHB first folds, between 18 ss and
24 ss. We found that the neuroepithelial MHB tissue angle decreases over time,
depicting the formation of the constriction. During this process, the MHB cells
shorten and narrow to enable the folding of the tissue, resulting in the formation of
a proper MHB with a deep MHB constriction (MHBC).

NMIIA and NMIIB differentially regulate zebrafish MHB morphogenesis
We hypothesized that non-muscle myosin II (NMII) proteins are required for
zebrafish MHB formation and we tested this by gene knockdown and consequent
confocal microscopic study and analysis. We determined a novel role for NMIIA
and NMIIB in regulating cell shape during zebrafish MHB morphogenesis. We
found that myh9b, a zebrafish ohnolog for the human MYH9 gene that encodes for
NMIIA, is responsible for the shortening of cells at the MHBC and myh10, encoding
for NMIIB, is required for cells throughout the MHB region to narrow (Chapter 2,
Figs. 12-13). The identification of a differential function for NMIIA and NMIIB in the
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formation of the zebrafish MHB led to the question of how they carry out these
distinct functions. We found that both proteins are not differentially localized within
the MHB but we observed differential disruption in actin distribution upon
knockdown of NMIIA and NMIIB (Chapter 2, Fig. 14).

Calcium regulates zebrafish MHB formation
We also hypothesized that calcium signaling plays a role in MHB development and
is an upstream regulator of NMII. To test the first hypothesis, we employed the use
of 2-APB, a drug that inhibits the release of calcium from the endoplasmic
reticulum (ER). We found that depletion of cytosolic calcium resulted in an
abnormal MHB angle and longer MHBC cells, showing that calcium is required for
zebrafish MHB formation (Chapter 3, Fig. 17). Interestingly, this phenotype is
similar to the phenotype seen with the knockdown of myh9b (Chapter 2, Figs. 1112), suggesting the possible involvement of calcium and NMII within the same
signaling pathway in MHB formation.
We further hypothesized that calcium signals to activate NMII. We had previously
determined that both NMIIA knockdown and cytosolic calcium inhibition result in
abnormal MHB with longer MHBC cells. We had also shown that knockdown of
mypt1, which corresponds to overactivation of NMII, also results in abnormal MHB
with shorter and wider MHB cells. Thus, if calcium signals to NMII, then
overactivation of NMII would be rescued by inhibition of cytosolic calcium. We
found that only the MHBC cell length phenotype seen in mypt1 morphants was
rescued upon 2-APB treatment (Chapter 3, Fig. 19). Since we have also
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determined that cell length is regulated by NMIIA (Chapter 2, Fig. 11), we further
hypothesize that calcium differentially signals to NMIIA, and not NMIIB.

B. FUTURE DIRECTIONS
How do NMIIA and NMIIB function differentially?
Although we have discovered distinct functions for NMIIA and NMIIB in zebrafish
MHB morphogenesis, the mechanisms by which they carry out their differential
function remains unknown. The following questions address different hypotheses
regarding how NMIIA and NMIIB may function differently to regulate cell shape and
outline future experiments to test each of these hypotheses.


Are NMIIA and NMIIB filaments oriented differentially?

Since we did not observe any difference in localization of NMII isoforms in the MHB
region, it is possible that the NMIIA and NMIIB fibers are oriented differentially. We
hypothesize that NMIIA fibers are oriented longitudinally, along the apical-basal
axis to regulate cell length, while NMIIB is oriented perpendicular to the apicalbasal axis of the cells, regulating cell width. Total internal reflection fluorescence
microscopy (TIRF) is a recent advancement in the field of microscopy, which
allows visualization at the level of single molecules and is dynamic, allowing us to
see the active processes going on inside living systems (Sako et al., 2000). While
the movement of NMII isoforms has been studied in a similar way using TIRF in
cell culture, visualization of single molecules in live organisms such as C. elegans,
medaka and zebrafish has also been made possible recently (Beach et al., 2014;
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Wang et al., 2010). To test our hypothesis, we could fluorescently tag NMIIA and
NMIIB to visualize the movement of the molecules along actin fibers using TIRF.
With respect to the cell shape changes occurring during zebrafish MHB
morphogenesis, we would expect to see NMIIA fibers move longitudinally along
the apical-basal axis and NMIIB molecules to move in the perpendicular direction.
This would provide an answer to the question of how NMIIA and NMIIB function
differentially during MHB formation in the zebrafish.


Can NMII function be regulated by molecules that differentially
phosphorylate the MLC of NMIIA and NMIIB?

The MLC of NMII is known to be phosphorylated by various kinases, two of the
most studied are Rho kinase and myosin light chain kinase (MLCK) (Betapudi,
2014). Since we have already determined that calcium regulates only MHBC cell
length, and not cell width, which corresponds to findings from NMIIA knockdown
phenotype (Chapter 3, Fig. 17), we hypothesize that the calcium-calmodulin
dependent MLCK phosphorylates NMIIA, while Rho kinase phosphorylates NMIIB.
To test this hypothesis, activation of MLCK can be inhibited using a
pharmacological drug, ML-7 (Saitoh et al., 1987), followed by a coimmunoprecipitation (co-IP) assay for pMLC with NMIIA and NMIIB, through
Western blotting analysis. We would expect to see reduced amounts of NMIIA in
ML-7 treated embryos, but no difference in NMIIB abundance. This would suggest
that MLCK phosphorylates NMIIA, but not NMIIB. Similarly, we would inhibit Rho
kinase using its specific inhibitor Y27632 (Ishizaki et al., 2000), and carry out a coIP and Western blot analysis of pMLC with NMIIA or NMIIB. We would expect to
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see reduced amounts of NMIIB in Rho inhibited embryos, but no reduction in
NMIIA levels. This will suggest that Rho preferentially signals to phosphorylate
NMIIB.


Can

differential

regulation

of

NMII

isoforms

occur

through

phosphorylation of the myosin heavy chain?
The NMII heavy chain has multiple phosphorylation sites, some of which are
specific to individual homologs. The NMIIA heavy chain has a ser-1943 site that
can be phosphorylated by casein kinase II. Absence of this phosphorylation
prevents its binding to s100A4, a member of the s100 family of calcium binding
proteins. This phosphorylation event results in inhibition of filament assembly,
disrupting its regular function (Vicente-Manzanares et al., 2009). The NMIIB heavy
chain also has a ser-1937 site phosphorylated by protein kinase C (PKC), which
is responsible for filament assembly (Vicente-Manzanares et al., 2009). These
distinct sites in the two homologs phosphorylated by different enzymes, but
carrying out the same function could indicate a differential regulation of the two
heavy chains. Using specific antibodies against each of these phosphorylated sites
on the heavy chains, we could carry out immunostaining to identify differences in
NMIIA and NMIIB protein localization. We would expect to see differential
localization of the phosphorylated forms of the two proteins which would help us
explain their respective differential functions.
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How does the calcium signaling pathway regulate zebrafish MHB
morphogenesis?
In this research, we have discovered a novel role for calcium signaling in regulating
cell length during zebrafish MHB morphogenesis. It remains to be determined if
and how calcium signaling regulates NMII during this process. The following
questions address this, and will help us to determine the specific pathway through
which NMII is regulated.


How can we confirm the efficacy of 2-APB at 24 ss?

We confirmed the efficacy of 2-APB in depleting cytosolic calcium levels by calcium
green-1 dextran, a calcium indicator (Chapter 3). However, this experiment was
carried out at 4 hpf, while all our experiments have been done in the time range of
18-24 ss. Since the fluorescence of calcium green-1 dextran does not give a good
signal at 24 ss, a different calcium indicator is required for better confirmation. This
can be done by using a genetically encoded calcium indicator, GCaMP. GCaMP6,
one of the recent sensitive and efficient calcium indicators for live visualization of
calcium, has been utilized for imaging in zebrafish (Chen et al., 2013). We have
obtained plasmid constructs of the GCaMP6 gene (a kind gift from Phillip Keller,
Howard Hughes Medical Institute) which can be utilized to synthesize mRNA and
inject it into single cell embryos, followed by imaging at a more relevant time point
to test for the efficacy of 2-APB. Time-lapse confocal imaging of 2-APB treated
embryos, upon comparison with control DMSO treated embryos would reveal
decreased amounts of fluorescent calcium, or loss of visualization of excitatory
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cells, and this will confirm the efficacy of 2-APB at 24 ss, the time-point at which
our experiments were carried out.


Do we need additional confirmation of the role of calcium in zebrafish
MHB development?

Signaling pathways involving calcium are complicated and difficult to study
because, unlike other signaling molecules that are products of cellular transcription
and translation, calcium is an inorganic diffusible molecule not synthesized by the
body. Studies on calcium signaling typically involve manipulation of its
concentration through pharmacological drugs that either increase or decrease its
cytosolic levels. Use of these drugs can result in variable effects in vivo versus in
vitro and this makes it important to test the functionality of the drug within in vivo
systems using tools such as the GCaMP6 calcium indicator described above.
Further, due to the nature of the drugs and variability in the efficacy of the drugs in
live organisms, it is important that more than one drug be used to confirm the
findings.
It is established that a major source of cytosolic calcium is by its release from the
ER and from previously published studies and our own findings, we know that
calcium levels can be regulated by manipulation of the IP3 receptors (Westfall et
al., 2003). Apart from 2-APB, other pharmacological drugs such as thapsigargin,
xestospongin C, and calcium ionophore A23187, which either increase or
decrease intracellular calcium levels, can be used to additionally confirm the
identified role of calcium in MHB morphogenesis (Westfall et al., 2003).
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Xestospongin C is similar to 2-APB, and inhibits IP3R, preventing the opening of
the calcium channels on the ER membrane (Gafni et al., 1997; Westfall et al.,
2003). Thapsigargin and ionophore A23187 work to increase the cytosolic calcium
levels. Treatment with thapsigargin inhibits the calcium-ATPase pump on ER
membranes, depleting calcium from the ER and resulting in increase in cytosolic
calcium. It also blocks the calcium pumps on the cell membrane, increasing influx
of calcium from outside the cell. However, it is important to note that once the drug
is washed out, the effect of the drug is reversible (Kluver et al., 2011; Westfall et
al., 2003). Calcium ionophore A23187 allows calcium from extracellular sources to
enter the cell, also causing an increase in intracellular calcium concentration (Lee
et al., 1999; Shu et al., 2007). Embryos can be treated with each of these drugs at
18 ss and imaged on the confocal microscope at 24 ss to quantify cell shape
changes. We would expect to see abnormal MHB tissue angle in each of the
treatment groups. Depending on the drug treatment we would predict different
effects on MHB cell shape. Xestospongin C treated embryos would show longer
MHBC cells while thapsigargin and ionophore treated embryos would show shorter
MHBC cells than in control. These experiments would help us determine whether
calcium has a role in regulating cell length during zebrafish MHB formation.


Is calcium an upstream regulator of NMII during zebrafish MHB
formation?

In order to determine if NMII is regulated by calcium upstream, we depleted
cytosolic calcium by 2-APB treatment and carried out a Western blot to determine
changes in pMLC levels (Chapter 3, Fig. S7). However, we did not find any
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observable reduction in pMLC abundance in wild-type or mypt1 morphant
embryos. MLC is a relatively small protein of 20 KDa size with low protein
abundance and it is possible that the decrease in protein level is not detectable by
Western blot. However, a small change in the amount of pMLC may still be
sufficient to cause significant changes in morphogenesis. As an alternative,
thapsigargin and calcium ionophore A23187 are both pharmacological drugs that
increase the amount of intracellular calcium, which could potentially improve
detection of changes in pMLC levels. Thus, we would expect to see an increase in
pMLC abundance in thapsigargin or ionophore treated embryos by Western
blotting. This would help us in determining if calcium signals to NMII.


Does calcium differentially signal to NMIIA?

The finding that calcium inhibition results in longer MHBC cells, along with rescue
of only the cell length phenotype in mypt1 morphants upon 2-APB treatment, led
us to hypothesize that calcium differentially signals to NMIIA. To test this
hypothesis, we would treat 18 ss embryos with 2-APB (or an alternate drug that
proves to be more efficient) and carry out a co-immunoprecipitation, by assaying
for pMLC and Western blotting for NMIIA and NMIIB. We would expect to detect
reduced amounts of NMIIA in the blot and no difference in levels of NMIIB. This
reduction in pMLC-NMIIA quantity upon inhibition of cytosolic calcium would
suggest that calcium signals differentially to NMIIA.
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What are the intermediate molecules in the calcium-NMII signaling
pathway?

We hypothesize that calmodulin and myosin light chain kinase (MLCK) mediate
the interaction of calcium with NMII (Chapter 3, fig. 20). Calmodulin is a calcium
binding protein that plays a role in yeast cell morphogenesis (Kraus et al., 2005;
Paranjape et al., 1990). CAM kinase II, a calcium/calmodulin-dependent protein
kinase, is important in developmental events such as cardiac and fin
morphogenesis (Rothschild et al., 2009). It is also expressed in the brain during
early development and is required for zebrafish brain morphogenesis (Hsu and
Tseng, 2010; Senga et al., 2013). This makes calmodulin a possible candidate
required for zebrafish MHB morphogenesis. Further, it has been shown that
calcium/calmodulin-dependent MLCK regulates NMII in renal collecting ducts
(Chou et al., 2004). Calmodulin 1a (calm1a) is specifically expressed at the MHB
during time points of interest and hence would be the ideal candidate (Friedberg
and Taliaferro, 2005; Thisse, 2001). The role of calmodulin can be studied by
morpholino mediated knockdown and mutants generated by targeted gene editing
of calm1a, followed by analysis of MHB cell shapes in 24 ss embryos. We would
expect to see longer MHBC cells in these morphants and knock out mutants, which
would result in wider MHB tissue angle, representing an abnormal MHB.
In order to test the role of MLCK in MHB morphogenesis, we could inhibit it with
the pharmacological inhibitor, ML-7 (Saitoh et al., 1987). ML-7 inhibits the
activation of MLCK, preventing its functioning. Alternately, a dominant-negative
construct for MLCK can also be used to prevent the normal functioning of the
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kinase (Shimizu et al., 2006). Embryos treated with either ML-7 or injected with the
dominant-negative MLCK could be analyzed for cell shapes at 24 ss using confocal
microscopy. If MLCK phosphorylates NMIIA, we would expect to see abnormal
MHB formation with longer MHBC cells. Additionally, a co-immunoprecipitation can
be done, by pulling down pMLC and Western blotting for NMIIA and NMIIB, in
conditions where MLCK is inhibited. We would expect to see a decrease in the
amount of NMIIA, and not NMIIB in the test group of embryos when compared to
control. A decrease in amount of pMLC-NMIIA upon inhibition of MLCK would
indicate that MLCK signals to NMIIA. This would allow us to conclude if our
hypothesis that MLCK differentially activates NMIIA is correct.

What are the signaling pathways regulating zebrafish MHB
morphogenesis?
Any morphogenetic event during development is a complex process involving
multiple signaling pathways. Hence, in order to tease out these pathways, a more
global approach is required. A proteomic mass spectrometric analysis of
embryonic brain tissue before and during MHB formation, and comparison of
changes in protein levels would help identify molecules that may regulate MHB
formation. It may also lead to discovery of novel molecules involved in this process.
After identification of potential molecules and signaling pathways, we could
specifically investigate individual downstream pathways to identify their roles in
zebrafish MHB formation.
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Thus, in this thesis, we characterized the cell shape changes occurring during
zebrafish MHB formation and discovered an important role for NMII proteins in this
morphogenetic process. We found that NMIIA regulates MHBC cell length and
NMIIB regulates MHB cell width. We also determined that calcium is required for
MHB morphogenesis, by its regulation of MHBC cell length. We further discovered
that only the MHBC cell length phenotype of NMII overactivation is rescued by
inhibition of calcium, which suggests possible differential regulation of NMIIA by
calcium signaling. However, further investigation is required to elucidate how NMII
proteins function differentially. These findings are likely to be similar in other
morphogenetic events and will help expand our knowledge of the molecular
mechanisms behind other developmental processes as well.
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